final program - ahpbanov 14, 2017 · 7–9 leadership & administrative team 10–13 general...

1 February 19–23, 2014 | MiaMi beach, FL — eden roc

February 19–23, 2014

Miami Beach, FL Eden Roc

Final Program

2014 Annual Meeting“Coming Together To Serve Our Patients”

5019 W. 147th StreetLeawood, KS 66224

Telephone: 913-402-7102 Fax: 913-273-9940 Email: [email protected]: www.ahpba.org

AHPBA_2014_FinalProgram-CMYKconvert.indd 1 2/12/14 9:39 AM


AdvancedEnergyCommitted to bringing open and laparoscopic solutions to HPB surgery

www.medtronicadvancedenergy.com

AHPBABooth

#1SLA-14-002573



TABLE OF CONTENTS

6 Meeting Support

7–9 Leadership & Administrative Team

10–13 General Meeting Information

14 CME & Learning Objectives

15–17 Distinguished Service Award

18–22 Research Award

23–25 Traveling Fellowship Recipients

26 International Relations Travel Grants

27 HPB Certificates of Completion

28–33 Chapter Information

34–37 AHPB Foundation

39–106 Meeting Agenda

108–111 Speakers & Faculty

114–115 Hotel Floorplans

116–126 Exhibitor Showcase Information

128–133 Membership Information

136 HPB Journal

135–137 IHPBA Kenneth Warren Foundation

138 Disclosures

140–141 In Memoriam

142–143 AHPBA Future Meetings



PrESidENT’S LETTEr

Welcome back to Miami and the Eden Roc for the 2014 Congress of the Americas Hepato-Pancreato-Billliary Association. I’m excited to be hosting this year’s conference and to highlight the success of our association.

As we begin our annual meeting I would like to give a special thank you to Bryan Clary and the entire Program Committee for their tireless work in bringing together a top-notch conference. The program will include a wide variety of topics, highly experienced speakers and some spirited debates.

President Elect Elijah Dixon has coordinated this year’s Postgraduate Course with controversial HPB topics, expansive case studies and a list of international experts. We hope you’ll join us for this invaluable experience.

Each year we invite some of the top leaders in our field to be guest speakers. We will welcome Göran Klintmalm, Chairman and Chief of the Baylor Regional Transplant Institute in Dallas/Fort Worth. Our historical lecturer will be J. Michael Henderson, Chief Quality Officer at the Cleveland Clinic Health System.

We’ve made a few enhancements to the meeting this year including changes to the CME process and a new meeting application. We’ll offer our CME program on-line. This new process should make getting your CME and self-assessment credits much easier. The meeting app provides meeting content, scheduling and logistic information, as well as general information and frequently asked questions.

AHPBA has continued to evolve and grow. The evidence of our success is seen across the board through committee work and management. We’ve recently transitioned to a new management company. LP etc has been working to improve our internal systems and processes to better manage all the details that go into running our organization at peak efficiency.

This year our Membership Committee is focused on expanding into the Americas and as a result we have added five new chapters in 2014: Canada, Guatemala, Mexico, Panama and Uruguay, to add to our four existing chapters of Argentina, Brazil, Chile and Ecuador. Currently we have six additional chapters pending:

William C. Chapman, MD



PrESidENT’S LETTEr continued

Bolivia, Costa Rica, Nicaragua, Peru, Dominican Republic, and Paraguay. This new expansion brings more resources, knowledge and experiences to our membership and is an exciting new direction for AHPBA. Welcome to all our new AHPBA members throughout the Americas.

We’ve also worked extensively on upgrading our web presence with a more user-friendly layout and a new Case of the Month feature. Our social media has been greatly expanded with the addition of an AHPBA YouTube channel, FaceBook page and a Twitter feed. Check our web page for links to all these features.

We encourage you to get involved in AHPBA by joining a committee. AHPBA offers over 225 committee positions. Regardless of your area of interest, you’ll find a position that fits and you’ll help support our growing organization.

Thank you for the opportunity to serve as President. Enjoy the meeting!

William C. Chapman, MDAHPBA President



The AHPBA wishes to thank the following organizations for their support of the 2014 Annual Meeting:

Gold

silver

bronze

General MeetinG support



AHPBA LEAdErSHiP

COMMITTEE CHAIRS Committee on Surgical Innovation James Moser, MD Development Nicholas Zyromski, MD Education & Training Rebecca Minter, MD Finance Committee Gazi B. Zibari, MD HPB Program Directors D. Rohan Jeyarajah, MD International Relations Sean Cleary, MD Membership Felipe Jose Fernandez Coimbra, MD Professional Development John D. Christein, MD Program Bryan M. Clary, MD Publications Timothy M. Pawlik, MD, MPH, PhD Research Sharon Weber, MD EX-OFFICIO Foundation President W. Scott Helton, MD

EXECUTIVE COUNCIL OFFICERS President William C. Chapman, MD President-Elect Elijah Dixon, MD, BSc, MSc Secretary Javier Lendoire, MD, PhD Treasurer Gazi B. Zibari, MD PAST PRESIDENTS Immediate Past President William R. Jarnagin, MD Past President Jean-Nicolas Vauthey, MD MEMBERS AT LARGE Horacio Asbun, MD

Jeffrey Barkun, MD

Todd Bauer, MD

Carlos Chan, Sr., MD

Michael D’Angelica, MD

Luiz Augusto Carniero D’Albuquerque, MD

Craig Fischer, MD, MPH

David A. Iannitti, MD

David Kooby, MD

Robert C.G. Martin, II, MD

Susan L.Orloff, MD

Charles Rosen, MD

Roderich E. Schwarz, MD, PhD

Charles M. Vollmer, MD



AHPBA LEAdErSHiP continued

AHPBA PAST PRESIDENTS William R. Jarnagin, MD

2012-2013

Jean-Nicolas Vauthey, MD

2011-2012

Reid B. Adams, MD

2010-2011

W. Scott Helton, MD

2009-2010

Mark P. Callery, MD

2008-2009

Bruce D. Schirmer, MD

2007-2008

Sean J. Mulvihill, MD

2006-2007

Theodore N. Pappas, MD

2005-2006

C. Wright Pinson, MD, MBA

2003-2005

Steven M. Strasberg, MD

2001-2003

Henry A. Pitt, MD

1999-2001

William C. Meyers, MD

1997-1999

J. Michael Henderson, MD

1995-1997

PROGRAM COMMITTEE Bryan M. Clary, MD 2014 Committee Chair

Thomas A. Aloia, MD – Co –Chair

Christopher D. Anderson, MD

Eugene P. Ceppa, MD

Clifford S. Cho, MD

Quyen D. Chu, MD, MBA

Sean P. Cleary, MD

Elijah Dixon, MD

Maria B. Majella Doyle, MD, MBA

Derek DuBay, MD

Ryan C. Fields,MD

Pamela J. Hodul, MD

Matthew H. Katz, MD

Milan Kinkhabwala, MD

Jennifer LaFemina, MD

Ajay V. Maker, MD

Henry B. Randall, MD

Srinevas K. Reddy, MD

Flavio G. Rocha, MD

Sharona B. Ross, MD

Courtney Scaife, MD

Shimul Shah, MD

Margo C. Shoup, MD

Conrad H. Simpfendorfer, MD

Kevin F. Staveley-O’Carroll, MD, PhD

Lee W. Thompson, MD

Ching-Wei D. Tzeng, MD

Charles M. Vollmer, Jr., MD

Rebekah White, MD



AHPBA LEAdErSHiP continued

AHPBA ADMINISTRATIVE TEAM Nonie Lowry Director, Association Management [email protected] Martha Lawrence Meetings Manager [email protected] Jill Kawulok Meetings Coordinator [email protected] Denise Higgs Registration & Membership Coordinator [email protected] Heather Roderick Exhibits & Sponsorship Coordinator [email protected]

americas Hepato-pancreato-biliary association

5019 W. 147th Street Leawood, KS 66224 USA

Telephone: 913-402-7102 Fax: 913-273-9940

Email: [email protected] Web: www.ahpba.org

Laura Fitzgerald Financial Manager [email protected] Kirsten Rencher Meetings Coordinator [email protected] Molly Edmondson Administrative Coordinator [email protected] Donia Robinson Webmaster [email protected] Amy Matthews CME Coordinator [email protected]



MEETiNg iNFOrMATiON

HOTEL INFORMATION eden roc 4525 Collins Avenue Miami Beach, Florida 33140 USA Telephone: 305-531-0000 Web: www.edenrocmiami.com AHPBA REGISTRATION DESk HOURS location: ocean tower i Foyer

Registration will be open throughout the meeting to provide assistance. Please let us know if there is anything we can do to help make your meeting experience more valuable. HOURS OF OPERATION Wednesday 6:30pm – 8:00pm

Thursday 6:30am – 6:30pm

Friday 6:30am – 6:00pm

Saturday 7:00am – 6:00pm

Sunday 7:30am – 1:00pm SPEAkER READy ROOM location: san Marino

Technicians will be available in the Speaker Ready Room for assistance with presentations. Please have your presentation in the room at least four hours prior to your presentation time. HOURS OF OPERATION Wednesday 6:00pm – 8:00pm

Thursday 6:30am – 6:30pm

Friday 6:30am – 5:30pm

Saturday 7:00am – 6:00pm

Sunday 7:30am – 11:00am



MEETiNg iNFOrMATiON continued

SAFETy & SECURITy We take every precaution to assure the safety and security of our attendees and their guests. However, we urge you to be aware and take simple steps to guard your possessions. Therefore, we suggest the following:

• Do not leave your purse or briefcase unattended.

• Do not leave your laptop, phone or PDAs on the floor or out of your sight.

• Be aware of your surroundings.

• If you do misplace or lose something, please contact the AHPBA Registration Desk immediately.

• To connect to hotel security please pick up a house phone or dial 305-531-0000. VIDEO SALES MEDCALDTV will be onsite providing videotaping of the educational sessions. You may place orders onsite, or via order form. The sales desk will be located near the AHPBA Registration area. Email: [email protected] Web: www.medicaldtv.com

MEETING APP aHpba 2014 annual Meeting has gone mobile! Be sure to download the 2014 AHPBA Meeting App for free on any smart device. To download, simply type www.eventmobi.com/ahpba into your web browser. A pop up button will appear asking you to download the app to your home screen. The AHPBA logo will appear as an app icon on your home screen and will allow you to instantly access the meeting app. Join the AHPBA 2014 Annual Meeting virtual community – it is an experience you won’t want to miss!




QR CODES Each registrant will receive a card with a unique QR CODE, which includes your name, institution and email address. You may choose to share your contact information with exhibitors or colleagues at the conference, and may do so simply by downloading a QR Code Scanner, which is available as a free app on your smart phone. SOCIAL MEDIA Stay current with meeting updates, discussions and colleague networking by connecting with AHPBA Social Media. It is easy! Follow us on Twitter (www.twitter.com/ahpba) and be sure to use the HASHTAG #aHpba2014 to link your comments to the AHPBA community. We are on Facebook too, www.facebook.com/ahpba. Simply “Like” our page and you will start receiving status updates on your newsfeed. Let’s get AHPBA trending, spread the word! WEBSITE AHPBA is proud to re-introduce you to our website, www.ahpba.org! Many enhancements, additions and updates have been made to improve quality and boost user experience. Is there something you would like to see added to the website? Let us know! Email [email protected]. We value your feedback in our continued efforts to make each web visit friendly and helpful!




TRANSLATED SESSIONS Translation from English to Spanish will be offered for the following sessions Friday

7:00am - 7:55am Parallel Education Breakfast Symposium: NAFLD - Implications for Liver Surgery

11:45am - 1:00pm Parallel State of the Art Lecture: Downsizing of HCC Prior to Transplant saturday

8:00am - 9:15am Parallel Symposium II: Screening for Pancreatic Cancer

9:15am - 10:00am Leslie H. Blumgart Historical Lecture

10:00am - 10:45am Parallel Update Lecture: ALPPS - An Update

11:15am - 12Noon Parallel Debates I: MIS Whipple - Viable Options in Today’s Economic Climate

12Noon - 1:00pm State of the Art Lecture: —Update on Intrahepatic Cholangiocarcinoma

1:00pm - 2:00pm Parallel Educational Lunch Symposia - Spanish Session *Spanish to English translation will be offered for this session

7:45pm - 9:30pm Parallel Educational Dinner Symposia: PNET Update AUDIENCE RESPONSE SESSIONS A limited number of sessions held in Tower I will include audience response on Thursday, Friday and Saturday.

Handsets will be distributed throughout the room for these sessions.



CME iNFOrMATiON

CME ACCREDITATION This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of PESI, Inc. and the Americas Hepato Pancreato Billiary Association (AHPBA). PESI, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA DESIGNATION STATEMENT The PESI, Inc. designates this educational activity for a maximum of 38 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

PHySICIAN ASSISTANTS AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME. LEARNING OBjECTIVES AND OUTCOMES The AHPBA 2014 Annual Meeting has been structured around various tracks, representing the liver, pancreas, biliary system and transplant. At the conclusion of the 2014 Annual Meeting of the AHPBA, the Association expects its attendees to have gained knowledge and skills that will lead to changes or enhancements in their own practices and improve physician training. The AHPBA expects that the 2014 Scientific Program’s educational interventions will result in measurable improvements in patient care. CME AND SELF-ASSESSMENT You may claim CME and Self-Assessment credits online at www.ahpba.org. Please complete the surveys and print your certificates bY FridaY, MaY 30tH. Up to 35 hours of self-assessment credit will be offered as a part of this educational activity.



diSTiNguiSHEd SErviCE AwArd

This year the AHPBA Council has unanimously chosen Dr. Steven Strasberg as the well-deserved recipient of the 2014 Distinguished Service Award.

“This award is a great honor. There are so many people I look up to and respect in this organization. To be recognized by those important contributors in our field is such a privilege,” says Dr. Strasberg.

Dr. Strasberg is a graduate of the University of Toronto Medical School and the Gallie Course in Surgery. He was an attending surgeon at the University of Toronto rising to the position of Professor of Surgery and was the first director of the Surgical Scientist Program. In 1992 he moved to Washington University in Saint Louis where he became Pruett Professor of Surgery and founding head of the Section of HPB Surgery. He has published approximately 250 peer reviewed papers and 50 book chapters and has held grants from the MRC and NIH. His current subject areas of interest

steven M. strasberg, MdWashington University

St. Louis, MO

Steven M. Strasberg, MD Washington University Medical Center St. Louis, MO



diSTiNguiSHEd SErviCE AwArd continued

are avoidance and management of biliary injury, classification and quantification of surgical complications, and development of novel anatomic approaches in HPB surgery.

The achievement most gratifying to Dr. Strasberg is bringing procedures into surgery to increase safety and efficacy. He has worked extensively on laparoscopic cholecystectomy using the “Critical View of Safety,” which has increased the safety of the operations. He has introduced new operations for cancer of the pancreas including a novel approach for resection called RAMPS. “If I had to pick what I am most pleased with when I look back on my career, it would be having a direct impact on surgery in terms of safety.”

Dr. Strasberg has been a long-time supporter of AHPBA and was involved in the formation meetings for the organization starting in 1994 as a member of the original Council. He organized the first AHPBA sponsored Post-Graduate Course during the 1994 AASLD meeting in Chicago. He fondly remembers the inaugural AHPBA meeting in 1997 at the Doral Resort in Miami. “There were only 97 members at the meeting and we used three rooms. The council members would take turns rotating into each room so they didn’t look empty.”

From 2001 to 2003 Dr. Strasberg served as AHPBA’s fourth President. During that time membership numbers grew to more than 400. Since his tenure as President, he has been an active participant in the organization and consistently attended the Annual Meeting. “Although the HPB field seems specialized, the AHPBA Annual Meeting brings together so many experts on very specific areas of knowledge and techniques. I come away from the meetings full of new knowledge and energized and excited about my work.”

Dr. Strasberg is optimistic about the future of AHPBA. Along with the close relationship with IHPBA, he sees a focus on continued close involvement with South and Central American chapters as critical to developing new strategies for managing HPB diseases. This global approach is developing new ideas, techniques and modalities for improved patient care.

Another area Dr. Strasberg would like to see expansion is through relationships with Industry. “These connections are so beneficial to our field. We can work with industry to bridge gaps in equipment and educational support.”



diSTiNguiSHEd SErviCE AwArd continued

This progressive approach is also reflected in AHPBA’s strong focus on teaching and development of fellows and residents. Dr. Strasberg hopes these programs continue to attract the best and brightest in the HPB field and to expose them to the benefits of joining AHPBA. According to Dr. Strasberg, “AHPBA is successful because of a devoted group of people. I would like to encourage the younger members to put in effort and keep us moving forward.”

As AHPBA expands, Dr. Strasberg appreciates the organization’s ability to retain it’s personality. “Although our membership and meeting continue to grow, the character of the organization hasn’t changed. We still feel like a big club.”

Dr. Strasberg enjoys time with his wife, children and grandchildren. “I would like to thank my wife, Yona, for her support. The Distinguished Service Award recognizes my service to our field and our patients. Without Yona’s support in all the other areas of our lives, I would never have had the time and focus to provide that service.”

Hemodynamic optimization through Perioperative Goal-Directed Therapy in moderate to high-risk surgery enhances recovery and is associated with a significant reduction in post-surgical complications and length of stay.1

Common surgical complications include acute kidney injury (AKI), anastomotic leaks, surgical site infections (SSI), urinary tract infection (UTI), pneumonia, and major/minor GI complications.

Visit us at booth #21.

Perioperative Goal-Directed Therapy

REDUCEDMORBIDITY BY 32%

REDUCEDLENGTH OF STAY BY1.16 D

AY

S

1. Grocott et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane systematic review. Br J Anaesth 2013

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. © 2014 Edwards Lifesciences Corporation. All rights reserved. AR10820

Edwards Lifesciences | edwards.comIrvine, California 92614 USA

REDUCEPOST-SURGICAL COMPLICATIONS



2012 rESEArCH AwArd uPdATE

Kevin C. Soares, MD

kevin C. Soares, MD Johns Hopkins Baltimore, MD From the Tumor Immunology Program, Departments of Surgery and Oncology, Johns Hopkins University School of Medicine

pd-1/pd-l1 blockade antibodies coordinate with vaccine therapy to overcome multiple immunosuppressive pathways and improve effector t cell infiltration in pancreatic adenocarcinoma

research synopsis: Pancreatic cancer (PDA) is highly resistant to standard treatment regimens and new therapies are sorely needed. Our phase I/II human clinical trials utilizing a GM-CSF secreting allogeneic pancreas tumor vaccine (GVAX) have been shown to be safe and tumor antigen specific responses have correlated with prolonged survival. However, pancreatic tumors consist of a strong immunosuppressive network, enabling tumor immune evasion and blunting vaccine-induced responses. Programmed cell death 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1) constitute a major tolerance mechanism. Clinical trials of αPD-1 and αPD-L1 antibodies have proven effective in solid tumors, although objective responses were not seen in a small subset of PDA patients. GVAX treated patients have demonstrated infiltration of PD-1+ T cells, which is a major immunosuppressive mechanism in the tumor microenvironment. We aimed to manipulate the PDA tumor microenvironment through the blockade of PD-1 or PD-L1 in combination with GVAX. We hypothesized that the use of PD-1 or PD-L1 blocking antibody and GVAX will improve vaccine therapy and pancreatic cancer survival. Immunohistochemistry analysis of human PDA resected from patients two weeks after GVAX therapy revealed significant upregulation of PD-L1 membranous staining compared to unvaccinated patients. Similarly, in a preclinical metastatic model of murine PDA, GVAX therapy significantly upregulated PD-L1 expression on neoplastic cells. We subsequently demonstrated that combinatorial therapy of GVAX with PD-1 blockade significantly improves survival and cure rates compared to vaccine and checkpoint monotherapy in a highly stringent pancreatic cancer murine model. Combinatorial therapy significantly increased effector T cell trafficking to the tumor microenvironment and overcame additional immune checkpoint mechanisms. Taken together, our findings support the combination of GVAX vaccine therapy with αPD-1 or αPD-L1 blockade in pancreatic cancer patients.



2013 rESEArCH AwArd uPdATE

Stephanie H. Greco, MD New York University School of Medicine, Department of Surgery New York, NY

regulation of acute pancreatitis by C-type lectin receptors (physiology/biology) research synopsis: My laboratory studies the role of the innate immune system in pancreatic and liver inflammation as well as in carcinogenesis. We have previously shown that blockade of certain pattern

recognition receptors (PRRs), in particular, Toll-Like Receptors 4 and 7 (TLR4 and TLR7), mitigates pancreatic inflammation and the progression to pancreatic cancer. My research focuses on the importance of Mincle, a novel PRR, in the above disease processes. The Mincle receptor is present on many different antigen-presenting cells (APCs), and has been shown to be critical for the immune response to mycobacteria and fungi. However, its role in models of pancreatic inflammation has never been studied. I have found that Mincle and its signaling intermediates are upregulated in a mouse model of acute pancreatitis. In addition, Mincle blockade decreases pancreatic immune infiltrate. Most significantly, I have discovered that Mincle and TLR4 co-associate on the cell surface, and that Mincle-/- mice have an increased response to TLR4 stimulation. These data suggest that Mincle negatively regulates TLR4 signaling. Regulation of TLR responses is extremely important in maintaining physiologic homeostasis and in limiting septic injury, tissue damage, and autoimmunity. My work seeks to elucidate the cellular mechanism of Mincle and TLR4 cross-talk and its importance in the pathogenesis of pancreatic inflammation. Knowledge of this interaction can ultimately lead to the development of therapeutic interventions for pancreatitis and pancreatic cancer.

Stephanie H. Greco, MD

the 2015 research award application deadline is January 5, 2015

Supported in part by the AHPBA Foundation and Sirtex Medical, Inc.



PAST rESEArCH AwArd rECiPiENTS

2013 Physiology/Biology Research Grant stephanie Greco, Md Regulation of Acute Pancreatitis by C-type Lectin Receptors New York University School of Medicine - Department of Surgery Supported by AHPBA 2012 Oncology Research Grant Kevin soares, Md Combinatorial Immunotherapy and the Manipulation of Tumor Microenvironment in the Treatment of Pancreatic Cancer Johns Hopkins Hospital Surgery Supported by AHPBA 2011 Oncology Research Grant Michele babicky, Md Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer University of California, San Diego Medical Center Supported by: AHPBA 2008 Surgical Technology Assessment and Outcomes Research Grant peter nau, Md Development of a Novel Repair Technique for latrogenic Common Bile Duct Injuries with a Biosynthetic Absorbable Graft The Ohio State University Medical Center Center for Minimally Invasive Surgery Supported by: Covidien and AHPBA 2008 Physiology/Biology Research Grant Kendra d. Conzen, Md The Role of HMGB1 in Steatotic Livers following Ischemia/Reperfusion Washington University Supported by: Ethicon, Inc. and AHPBA



PAST rESEArCH AwArd rECiPiENTS continued

2008 Oncology Research Grant Wigdan al-sukhni, Md An Analysis of Germline Genomic Copy-number Variation to Identify Disease-Associated Gene(s) in Familial PancreaticCcancer University of Toronto Supported by: Sanofi Aventis and AHPBA 2007 Covidien Surgical Technology Assessment lia roque assumpcao, Md Application of Novel, High Resolution, and Freehand Ultrasound Elasticity Imaging in Liver Surgery Johns Hopkins University Hospital 2007 Sanofi-Anventis HPB Oncology bedabrata sarkar, Md Characterization of Pancreatic Cancer Stem Cells University of Michigan Medical School 2007 Ethicon HPB Physiology/Biology lee ocuin, Md Immune Activation of Human Liver Dendritic Cells Memorial Sloan-Kettering Cancer Center 2006 Ethicon HPB Physiology/Biology luis Garcia, Md Targeted Inhibition of VEGF Prevents Development of Tumor Antigen-Specific T-Cell Tolerance in the Murine Liver The Milton S. Hershey Medical Center 2006 Sanofi-Aventis HPB Oncology Jon Cardinal, Md Crossroad in Cancer Signaling: Regulation of Human iNOS Expression by the WNT B-Catenin Path University of Pittsburgh



PAST rESEArCH AwArd rECiPiENTS continued

2005 Ethicon HPB Physiology/Biology sunil K. Geevarghese, Md The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion Injury following Syngeneic Rat Liver Transplantation Vanderbilt University Medical Center 2005 Sanofi-Aventis HPB Oncology Jon dorfman, Md Positron Emission Tomography to Monitor HSV-2 Viral Oncolysis Massachusetts General Hospital 2004 Ethicon HPB Jennifer lynn irani, Md The Role of CEACAM6 in Pancreatic Cancer Invasion Brigham and Women’s Hospital 2003 Ethicon HPB shiva sarraf-Yazdi, Md Anti-angiogenic Therapy of Murine Liver Metastases by Tie2 Inhibition Duke University Medical Center 2002 Ethicon HPB Charles M. vollmer, Md Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer University of Toronto 2001 Ethicon HPB nicole Chandler, Md Overcoming Chemoresistance in Human Pancreatic Cancer Beth Israel Deaconess Medical Center



2013 TrAvELiNg FELLOwSHiP rECiPiENTS

Adnan A. Alseid, MD, EdM Digestive Disease Institute Destination: National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico. Hosts: Carlos Chan Nunez, MD , Miguel a Mercado, MD INNSZ Fellows: Ismael Dominguez Rosado, MD, Daniel Zamora-Valdés, MD

I had the sincere privilege of being awarded the AHPBA 2013 traveling Fellowship award. This generous gift allowed me to travel to Mexico City

to work with and learn from my amazing hosts Drs Carlos Chan and Miguel Mercado at the national Institute of medical science and nutrition Salvador Zubiran (INNSZ). While the focus of my travel was initially educational with the intention to study and work on their HPB Fellowship, a clinical component to the trip naturally materialized.

Educationally; it was truly refreshing to see a rather energetic educational atmosphere with a very vibrant and strong residency and HPB education for both Fellows and residents. I had the opportunity to participate in tumor boards, multidisciplinary HPB rounds, observe both residents and Fellows in the operating room with incredible autonomy, and I was given the privilege of lecturing to the house-staff on curricular design of educational programs and methods to improve and assess psychomotor skills and learning.

Clinically; I was rather impressed with the HPB experience that exists at INNSZ. Particularly with the incredibly high volume, almost 2 to 3 per week, of bile duct repairs that were being reformed. This is clearly recognized as a public health problem at INNSZ. I was honored to be allowed to participate in the creation of a bile duct injury prevention workforce. This workforce will be an integral part of the Mexican-AHPBA meeting in December of 2014. Action items to include a formal assessment of the problem, educational literature in Spanish for general surgeons to change the culture of open/laparoscopic cholecystectomy, and methods of prevention and early recognition of injuries were created and are already being worked on.

In the end I am truly in debt to my hosts for allowing me into their busy schedules and their homes, for the generosity, and for allowing me to participate in their public health measures. I also would like to thank the AHPBA Foundation for selecting me for this important award.

Adnan A. Alseid, MD, EdM



2013 TrAvELiNg FELLOwSHiP rECiPiENTS continued

Ruben Rodrigo Lozano-Salazar, MD Hospital Regional De Alta Especialidad de La Peninsula de Yucatan Destination: Seattle, WA I feel really honored to be awarded with the 2013 AHPBA Travelling Fellowship Award. I have known Dr. Scott Helton for many years, as he has been part of several hepato-pancreato-biliary (HPB) meetings in Mexico, during my training years. I am working in a relatively new Hospital, and tasked with developing an HPB program, so I felt that this could be a great opportunity to observe a fully operational HPB service.

Therefore, I made my plans to visit the Liver, Pancreas and Biliary Surgical Center of Excellence at the Virginia Mason Medical Center (VMMC) in Seattle.

During my visit, I witnessed how the surgery, endoscopy, radiology, oncology and pathology services work as a team, with fluent and rapid communication, in order to give the patient the best treatment with a warm human touch. This was particularly evident in the evaluation and management of patients with localized and borderline resectable pancreatic cancer. In my two-week stay in Seattle, I took part of the clinical rounds; I participated in the gastrointestinal and pancreas tumor board, the morbidity & mortality sessions, and conferences to discuss their current outcomes and research. I attended several surgical procedures including benign and malignant HPB disease, and during all those moments in the operation room, the surgeons and all the staff in there made me feel like part of their team. I even had the chance to support the Seahawks on their road to the Super Bowl.

I am really grateful to all the people at the VMMC who spent their time and share their knowledge with me. Thank you very much to Scott Helton, MD, Flavio G. Rocha, MD, Tom Biehl, MD, Adnan Alseidi, MD and Bart Rose, MD in the Department of Surgery, Michael Larsen, MD in the Department of Therapeutic Endoscopy. I would like to thank the AHPBA Foundation and the AHPBA Executive Council for this unique opportunity in my academic formation. I hope that I could return to the AHPBA in a nearby future with the first achievements of a newly created HPB service in my Hospital in Mérida, México.

Ruben Rodrigo Lozano-Salazar, MD

the 2014 traveling Fellowship application deadline is april 1, 2014

Supported in part by the AHPBA Foundation and Sirtex Medical, Inc.



2013 TrAvELiNg FELLOwSHiP rECiPiENTS continued

Jiping Wang, MD, PhD

jiping Wang, MD, PhD Brigham and Women’s Hospital Destination: Buenos Aires, Argentina Host: Alberto R. Ferreres, MD, PhD, FACS It was a great honor to receive this travel fellowship and had the precious opportunity to visit the HPB programs in Argentina. My visit started with a full day with Drs. Javier Lendoire, MD, PhD and Fernando Duek, MD. They gave me an introduction of the HPB program in Buenos Aires and demonstrated the 2nd phase of liver resection

for a 2-stage operation on a patient with CRCLM at a community facility. The 2nd day, I was introduced to Dr. Oscar Imventarza at Hospital de Pediatria “Dr. Juan P. Garrahan”. I observed a pediatric liver transplantation case and learned the difference between adult and pediatric liver surgeries. Then, I went to Sanatorio Colegiales, where I observed a gallbladder cancer case with portal dissection and segment IVb and V resection by Dr. Fernando Duek. I spend two days at Hospital Italiano de Ruenos Aires. On the first day, Dr. Juan Pekojl demonstrated a case of laparoscopic CBD exploration for intrahepatic lithiathis case and left lateral liver resection. This was followed by a case of laparoscopic enucleation of a cystic lesion in the head of pancreas. On the second day, a planned Klatskin tumor case was cancelled due to metastatic disease. This gave me a precious opportunity to have case discussion with Dr. Pekojl and he showed me some pearls and tricks in liver surgery including ALLPS. Then I visited Hospital Universitario Austral and observed an extended right hepatectomy for a CRCLM involving the middle hepatic vein. My visit was highlighted by my visit at “Dr. Carlos A. Bocalandro” Hospital. I participated in the discussion with Dr. Alberto Ferreres and his residents for a patient with Mirrizi’s syndrome and an operative case of neuroendocrine tumor at the body of pancreas with liver metastasis. In summary, this was an incredible experience and it won’t happen without AHPBA’s support. More importantly, without Dr. Alberto R. Ferreres’s generosity in arranging all the activities, it will not be so productive. In a very short amount of time, I had the tremendous opportunity to observe other experts’ work, share ideas and exchange clinical experience in patient management. Indisputably, through the professional relationships developed, future collaboration will be fostered. The technique pearls that I learned during this visit will be incorporated into my future practice and will benefit patients. I would like to thank the AHPBA again for this exceptional opportunity.



iNTErNATiONAL rELATiONS TrAvEL FELLOw grANTS

2014 RECIPIENTS

Sergio Manuel Lopez Torrez, MD, MSc Nicaragua Alvaro Andres Duarte Garces, MD Columbia jaime Arthur Pirola kruger, MD Brazil Hoover Rodyl Henriquez Cooper, MD Honduras

Supported in part by the AHPBA Foundation



2013 HPB CErTiFiCATES OF COMPLETiON rECiPiENTS

Congratulations to the following members who have successfully completed their fellowship training and have fulfilled the surgical curriculum requirements, as set forth by the AHPBA and Fellowship Council. These individuals will be recognized during Friday’s opening session.

Saleh Al-Abbad, Md McGill University Health Center Erin C. Maynard, Md Washington University School of Medicine Houssam Osman, Md Methodist Dallas Medical Center Erik M. dunki-Jacobs, Md University of Louisville School of Medicine daniel Eduard Kleiner, Md Washington University School of Medicine Pablo E. Serrano, Md Toronto General Hospital Kevin M. El-Hayek, Md Cleveland Clinic Charles H.C. Pilgrim, Md, Phd Medical College of Wisconsin Ching-wei david Tzeng, Md MD Anderson Cancer Center victor Michael Zaydfudim, Md Mayo Clinic

Neil H. Bhayani, Md, MHS Penn State Milton S. Hershey Medical Center Sung w. Cho, Md Providence Portland Medical Center Sameer damle, Md Virginia Mason Medical Center Juan C. Mejia, Md University of Pittsburgh Medical Center Massimo Arcerito, Md University of Michigan Health System Bassam Abu wasel, Md Dalhousie University, Queen Elizabeth II Health Sciences Centre Janak A. Parikh, Md Indiana University Hospital Andrei Cocieru, Md Duke University Medical Center Kerri A. Simo, Md Carolinas Medical Center



2014 NEwLy ESTABLiSHEd AHPBA CHAPTErS

Canada Sean P. Cleary, MD The Canadian Hepato-Pancreatico-biliary Association was formed over a decade ago by Francis Sutherland and Michael Marcaccio as an organization to promote and coordinate professional, educational, research and social activities among HPB surgeons in Canada. The CHPBA works closely with the Canadian Association of General Surgeons to provide HPB related content, invited lectureships and continuing medical education to Canadian surgeons through local and national meetings.

There are currently 62 Canadian members of the AHPBA that also belong to the CHPBA. While Canadian members have always played a prominent role and made significant contributions to the AHPBA, the incorporation of the CHPBA as a chapter of the AHPBA is a tremendous honour that will provide important support and guidance in expanding the educational activities for HPB surgeons in Canada through consensus conferences, meetings, lectureships and courses.

The Executive committee of the CHPBA consists of a President (Sean Cleary), President-elect (Shiva Jayaraman), Vice President (Jeff Barkun), Secretary (Chad Ball) and 2 members-at-large (Elijah Dixon and Francis Sutherland). This group meets bi-annually in person at the Canadian Surgical Forum and the AHPBA Annual meeting.

Sean P. Cleary, MD



2014 NEwLy ESTABLiSHEd AHPBA CHAPTErS continued

Guatemala Erick Roberto Soto Solís, MSc., MACG With my participation in the 2nd. Congress AHPBA Chapter Ecuador in The Galapagos Islands, began the dream of establishing the Guatemalan Chapter, with the unconditional support of Dr. Nestor Gomez and with the collaboration of Dr. Javier Lendoire, I returned to my country with this goal. I talked about that possibility with some colleagues and on December 2013 with the participation of 6 members, the dream came true.

Our expectation is to increase our members both nationally and Central America area and the primary purpose is the benefit of all patient with HPB pathology through the exchange of knowledge and improving the skills of already trained specialists and encouraging future generations. Con mi participación en el 2do. Congreso AHPBA Capítulo Ecuador en las Islas Galápagos, inició el sueño de establecer el Capítulo Guatemalteco, con el apoyo incondicional del Dr. Néstor Gómez y con la colaboración del Dr. Javier Lendoire, regresé a mi país con esa meta. Hablé de esa posibilidad con algunos colegas y en Diciembre 2013 con la participación de 06 miembros, el sueño se hizo realidad.

Nuestra expectativa es incrementar nuestros miembros tanto a nivel nacional como del área Centroamericana y el objetivo primordial es el beneficio que obtendrá todo paciente con patología HPB por medio del intercambio de conocimientos , mejorando así las capacidades de los especialistas ya

entrenados e incentivando a las futuras generaciones.

Erick Roberto Soto Solís, MSc., MACG




Mexico Carlos Chan, MD Mexico National Chapter was created in July 2013 during the first Congress of the Mexican Hepato Pancreato Biliary Association in the city of Cancun.

We had a great meeting with speakers from all the Americas from Canada to Argentina. We had the presence of William Chapman, President of AHPBA and many members of the executive council.

During this meeting many new members for AHPBA/IHPBA were recruited.

We are very happy to start this new adventure with the creation of the new Mexican Chapter of AHPBA/

IHPBA.

El Capitulo Mexico de la AHPBA, fue creado en Julio del 2013 durante el primer congreso de la Asociacion Mexicana Hepatopancreatobiliar en la Ciudad de Cancun.

Tuvimos un extraordinario congreso con profesores de toda America desde Canada hasta Argentina. Tuvimos el honor de tener al Dr. William Chapman, presidentede la AHPBA asi como a varios miembros del comite ejecutivo.

Durante este evento, se afiliaron muchos miembros nuevos tanto para AHPBA como IHPBA.

Nos sentimos muy contentos de empezar esta nueva aventura con la creación de este nuevo Capitulo Mexicano de la AHPBA/IHPBA.

Carlos Chan, MD




panama Moises Cukier, MD The Panama Chapter of the AHPBA was created in August, 2013. Following the advice and support of Dr. Sean Cleary (International Relationships) and Dr. Nestor Gomez (founder of the Ecuatorian Chapter) at the AHPBA Annual Meeting 2013, the panamenian surgeons members of the AHPBA decided to create and formalize a group with the goal of promoting academic HPB surgery in Panama as well as exchanging experiences with colleagues in the Americas. This chapter has begun with 7 members and is looking forward to collaborate actively with the AHPBA and other Chapters. The current president is: Moises Cukier, MD (Surgical Oncologist - HPB)

El Capítulo de Panamá de la AHPBA fue creado en Agosto, 2013. Siguiendo el apoyo y los consejos del Dr. Sean Cleary (Relaciones Internacionales) y del Dr. Nestor Gomez (fundador del Capítulo de Ecuador) en la Reunion Anual del AHPBA 2013, los cirujanos panameños miembros del AHPBA decidieron crear y formalizar un grupo con el objetivo de promover la cirugía hepatopancreatobiliar académica en Panamá así como intercambiar experiencias con colegas del continente americano. Este capítulo ha empezado con 7 miembros y espera colaborar activamente con la AHPBA y otros capítulos regionales. El presidente actual es: Dr. Moises Cukier (Cirugía Oncológica - HPB).

Moises Cukier, MD




uruguay Hernan E. Parodi, MD The Uruguayan Society of Surgery, founded in 1920, it is a scientific and professional association that congregates all surgeons of our country. As a apart of this Society, in July of 2012, the HBP Chapter was created, with its own authorities, monthly meetings and an annual course in the Uruguayan Surgery Congress.

In November of 2013 we have organized the 1st International Course of AHPBA in Montevideo, with the assistance of Canadian and Argentine surgeons and the support .

Dr. Luis Ruso Martinez was the first president of this Chapter, role recently attributed to Dr. Hernan Parodi. Our Chapter have nowadays 12 partners of both AHPBA and IHPBA.

The main objective of this chapter is to offer an advanced continuous medical education in the field of HPB for all surgeons of the country, as well as, provide opportunities to young surgeons and exchange experience in an international level. La Sociedad de Cirugia del Uruguay , fundada en 1920 es la asociación científica y profesional que congrega a todos los cirujanos del país.- Como parte de la misma en julio de 2012 fue creado el Capitulo HPB con sus autoridades propias, reuniones científicas mensuales y un curso anual en el Congreso Uruguayo de Cirugia.

En noviembre de 2013 se realizo el 1º curso internacional de AHPBA en Montevideo, con la asistencia de cirujanos argentinos y canadienses.- El Dr.Luis Ruso Martinez, fue el primer presidente y recientemente ha sido electo el Dr.Hernan Parodi.- Nuestro Capitulo tiene actualmente 12 socios que integran la AHPBA y la IHPBA.

El objetivo del Capitulo es ofrecer CME de avanzada en el campo HPB a todos los cirujanos del país, asi como oportunidades de formación a los cirujanos jóvenes e intercambio de experiencia a nivel internacional.

Hernan E. Parodi, MD



ExiSTiNg AHPBA CHAPTErS

argentina Oscar Imventarza, MD

brazil Orlando jorge Martins Torres, MD

Chile Heran De la Fuente, MD

ecuador Eduardo Rivas, MD



AmericAs HepAto-pAncreAto-BiliAry

FoundAtionAdvancing Research, Education, Training & Philanthropic Endeavors

donate todaY

ahpba.org/ahpba-foundation

The AHPBF has made great strides towards reaching its short term goal

of generating a $1 million endowment.

Your contribution will help us get one step closer in reaching our goal.



ABOUT THE AHPBA Research and education are the cornerstones to advancing the treatment of hepato-pancreato-biliary diseases. The AHPBA Foundation is dedicated to funding research and education opportunities so our colleagues can directly impact HPB diseases.

Established in 2010, the Americas Hepato-Pancreato-Biliary Foundation (AHPBF) seeks to support the academic careers of young researchers in the study of diseases of the liver, bile duct and pancreas. By fostering and advancing the educational, research and training activities of the Americas Hepato-Pancreato-Biliary Association, we enhance the quality of hepato-pancreato-biliary surgery and patient care.

Research, education and training are dramatically increasing the quality of surgery and treatment. Most importantly, our patients see the direct results of our commitment to relieve the human suffering caused by HPB disorders throughout the world.

FOUNDATION PROjECTS INCLUDE

• International Outreach Grants allowing South, Central and Latin American members to attend the Annual Meeting.

• Annual Research Grants working toward treatment and surgery innovations.

• Traveling Fellowship Grants for U.S. Fellows traveling abroad.

• Historical Lecturer Honorarium to bring leading-edge speakers to the Annual Meeting.

• Humanitarian projects providing access to HPB care for patients.



GIFT LEVELS The AHPBF has made great strides towards reaching its short term goal of generating a $1 million endowment. Your contribution will help us get one step closer in reaching our goal.

DIAMOND $10,000 and above

PLATINUM $5,000 and above

GOLD $1,000 and above

SILVER $500 and above

BRONzE $250 and above

CONTRIBUTORS under $250

MULTI-yEAR PLEDGE OPPORTUNITIES Multi-year pledges provide a long-term giving commitment to AHPBF projects and allow donors a low-maintenance planning tool. Designate a Diamond, Platinum or Gold gift over a five year period.

COMMEMORATIVE GIVING AHPBF donors may designate gifts in honor or memory of an individual. Designees will receive a notice of your gift and its use toward supporting surgical research. We provide your name and address unless otherwise indicated, however, gift amounts remain confidential. Designees will be listed in all relevant AHPBF programs and public information materials. The Americas Hepato-Pancreato-Biliary Foundation (AHPBF) is a 501(c) (3), not-for profit

organization. Donations are fully tax-deductible to the extent allowed by law. Please consult your

accountant for details. Tax ID: 27-4355142

AHPBA FOuNdATiON



AHPBA FOuNdATiON dONOrS Contributions as of January 31, 2014

DIAMOND AHPBA Roche Pharmaceutical GOLD Reid Adams Adnan Alseidi Mark Callery William Chapman Sean Cleary Michael D’Angelica Elijah Dixon O. James Garden Paul Greig William Helton David Iannitti IHPBA Michael Jacobs William Jarnagin Daniel Kleiner Keith Lillemoe Rebecca Minter Michele Molinari Sean Mulvihill Susan Orloff C. Wright Pinson Henry Pitt Charles Burke Rosen Bruce Schirmer Roderich Schwarz Jean-Nicolas Vauthey Charles Vollmer Gazi Zibari

SILVER John Christein Felipe Coimbra Alessandro Diniz Andrew Lowy Purvi Parikh BRONzE Jeffrey Barkun Cristina Ferrone Javier Lendoire Susan Logan Juan Pekolj Flavio Rocha Ponnandai Somasundar Steven Strasberg Kevin Watkins CONTRIBUTOR Thomas A. Aloia Christopher Anderson Todd Bauer Melanie-Antoinetta Brown Efrain Cambronero Mark Cattral Yun Shin Chun Bryan Clary Wilson Luiz Costa Jr Raul Cutait Yoshio Deguchi Douglas Evans Riad Haddad

Ellen Hagopian D. Ryan Hall Ruth Haynes Paulo Herman Defei Hong Oscar Imventarza D. Rohan Jeyarajah Tara Kent Kourosh Kojouri David Kooby Bernard Langer Jeffrey Lee Donald Lesslie Lucas McCormack Peter Muscarella Attila Nakeeb Marshall Orloff Martin Palavecino Hernan Parodi Mayank Roy Margo Shoup David Sindram Atsushi Sugioka Rebekah White Randall Zuckerman

We are proud to recognize our donors and would like to thank all of the Organizations and Individual Supporters whose continued generosity allows us to promote the research on diseases of the liver, pancreas and biliary tract.


Experience da Vinci Technology at the Intuitive Surgical Booth

EndoWrist® One™ Vessel Sealer EndoWrist® Stapler 45

Firefly™ Fluorescence Imaging


39 February 19–23, 2014 | MiaMi beach, FL — eden roc 39

AgENdA



7:00am - 8:00am ultrasound registration and breakfast Mona Lisa Foyer 7:45am departures for Golf & Fishing Main Lobby 8:30am - 1:00pm aHpba Foundation - Golf tournament Miami Beach Golf Course Fee: $200 per person 8:00am - 1:00pm aHpba Foundation – Fishing tournament Fee: $200 per person 7:00am - 5:30pm

Ultrasound Didactic Course Support for this course provided by Angiodynamics, BK Medical, Hitachi Aloka Medical, Ltd., Inner Optic, Kyoto, Medtronic Advanced Energy, Pathfinder Technologies, Inc., and 3D Med

Mona Lisa – Didactic Course Key Biscayne A/B – Hands-On Session Moderator & Organizer: Ellen J. Hagopian, MD 7:00am Registration & Breakfast 8:00am Welcome & Introduction Ellen J. Hagopian, MD 8:05am Importance of Ultrasound in HPB Surgery Ellen J. Hagopian, MD 8:15am US Principles & Instrumentation Eren Berber, MD 8:45am US Scanning Techniques: TAUS, IOUS & LAP Reid B. Adams, MD

WednesdaY, FEBruAry 19, 2014




9:05am Liver US: Normal Anatomy & Pathologic Findings Paul D. Hansen, MD 9:45am Break 10:00am Gallbladder & Bile Duct US: Normal Anatomy & Pathology O. James Garden, MD, FRCSEd 10:20am Pancreas US: Normal Anatomy & Pathologic Findings D. Rohan Jeyarajah, MD 10:40am Introduction to Hands-On Sessions Ellen J. Hagopian, MD 10:50am Break 11:00am HPB Anatomy & Technique: TAUS All Faculty 12Noon - 1:00pm

Lunch Belle 1:00pm Techniques in Ultrasound Guidance: TAUS, IOUS & LAP David A. Iannitti, MD 1:20pm Methods of Tumor Ablation in HPB Surgery Robert C.G. Martin, II, MD, PhD 1:40pm US Coding & Billing for the Surgeon Robert C.G. Martin, II, MD, PhD 2:00pm Getting Started & Credentialing Ellen J. Hagopian, MD 2:20pm Break 2:30pm Scanning Methods & Ultrasound Guidance: IOUS & LAP Hands-On Lab using inanimate and phantom models 2:00pm - 3:00pm Membership Committee Meeting LaGorce




2:00pm - 3:00pm professional development Committee Meeting Fisher A 2:00pm - 3:00pm development Committee Meeting Fisher B 3:15pm - 4:15pm publications Committee Meeting LaGorce 3:15pm - 4:15pm international relations Committee Meeting Fisher B 3:15pm - 4:15pm Finance Committee Meeting Fisher A 4:00pm - 6:00pm

Allied Health Care Symposium Watson Room Moderators: Timothy Pawlik, MD, PhD & Lindsey Manos, PA-C 4:00pm Introduction 4:10pm Integrating Allied Health Providers to a Busy, Successful HPB Practice Dave Geller, MD 4:30pm Standardization of Postoperative Management for Whipple & Distal Pancreatectomy Patients Erin McIntyre, PA-C 4:50pm Philanthropy: A Collaborative Approach Sharon Weber, MD Mary Beth Henry, CRNP




5:10pm Inpatient Management of HPB Patients: The Wake Forest Baptist Health Experience Nathan Ogilvie, PA-C 5:30pm Open Discussion 4:30pm - 5:30pm program Committee Meeting Fisher A 4:30pm - 5:30pm education & training Committee Meeting La Gorce 4:30pm - 5:30pm Csi Committee Meeting Fisher B 5:45pm - 6:45pm research Committee Meeting Fisher B 5:45pm - 6:45pm aHpba Foundation board Meeting LaGorce 5:45pm - 6:45pm Hpb program directors Meeting Fisher A 6:00pm - 8:00pm speaker ready room open San Marino 6:30pm - 8:00pm aHpba registration open Ocean Tower 1 & 2 Foyer 7:00pm - 9:00pm aHpba executive Council Meeting Ocean Ballroom IIA


44 FEBRUARY 19–23, 2014 | MIAMI BEACH, FL — EDEN ROC

THURSDAY, FEBRUARY 20, 2014

6:30am - 6:30pm AHPBA Registration Open Ocean Tower 1 & 2 Foyer 6:30am - 6:30pm Speaker Ready Room Open San Marino 7:00am - 9:00am AHPBA Executive Council Meeting Ocean Ballroom IIA 9:30am - 5:00pm

Postgraduate Course: Cases, Complications & Controversies Support for this session provided by Medtronic Advanced Energy

Ocean Tower 1 A-C Moderator & Organizer: Elijah Dixon, MD, BSc, MSc

9:30am Pancreas Moderator: Charles M. Vollmer, MD

Panelists & Case Discussion Mark S. Talamonti, MD Chad G. Ball, MD David E. Linehan, MD Nicolas P. Jarufe Cassis, MD Katherine Morgan, MD

10:45am Debate: Optimal Whipple Outcomes: System or Surgeon Andrew L. Warshaw, MD Mark S. Talamonti, MD

11:30am Lunch Break


tHursdaY, FEBruAry 20, 2014

12:30pm Hepatic Moderator: Paul D. Hansen, MD

Panelists & Case discussion Thomas A. Aloia, MD William R. Jarnagin, MD Steven M. Strasberg, MD Alice C. Wei, MD Paulo Herman, MD

1:45pm Debate: Management of Disappearing Liver Metastases David M. Nagorney, MD O. James Garden, MD, FRCSEd

2:30pm Break

3:00pm Transplantation Moderator: Paul D. Greig, MD

Panelists & Case discussion Alan W. Hemming, MD Maria B. Majella Doyle, MD, MBA Oscar Cesar Imventarza, MD Susan L. Orloff, MD Michele Molinari, MD

4:15pm Debate: Living Donor Liver Transplantation Should Be Offered to All Wait-Listed Patients William C. Chapman, MD 11:30pm - 1:00pm new Member lunch (By invitation only) Spa Gardens (Rain Backup: Lapidus/Watson) 5:15pm - 6:45pm Welcome reception Pompeii/Promenade




5:15pm - 6:45pm industry exhibits open Pompeii/Promenade 6:00pm - 7:30pm

Educational Dinner Symposium: Robotics in HPB Surgery Support for this session provided by Intuitive Surgical Ocean Tower 1 A-C Moderator: Eugene P. Ceppa, MD

Introduction Eugene P. Ceppa, MD

Current Status of Robotic Hepatectomy/Biliary Recostruction John B. Martinie, MD

Current Status of Teaching Robotic Pancreatectomy Melissa E. Hogg

Advantages and Disadvantages of Robotic Pancreatectomy C. Max Schmidt, MD

Panel Discussion John B. Martinie, MD; Melissa E. Hogg, MD; C. Max Schmidt, MD 6:45pm - 7:45pm Hpb Fellows subcommittee Meeting LaGorce




7:45pm - 10:15pm

Bernard Langer Fellows and Residents Symposium: Why to Choose HPB Surgery, How to Get a job in HPB Support for this session provided by Ethicon, Inc.

Ocean Tower 1 A-C Moderator: D. Rohan Jeyarajah, MD

— PART 1: Why Choose HPB Surgery? Noaman Ali, MD & D. Rohan Jeyarajah, MD

Do We Really Need More HPB Surgeons? Noaman Ali, MD

How Do I Become an HPB Surgeon? a. Transplant - Raashid Sheikh, MD b. Surgical Oncology – Amanda Cooper, MD c. HPB Fellowship – Noaman Ali, MD

How Are We Training HPB Surgeons? D. Rohan Jeyarajah, MD

Panel Discussion

— PART 2: How Can I Get an HPB job? Ramanathan Seshadri, MD & Maria B. Majella Doyle, MD, MBA

Introduction Ramanathan Seshadri, MD

My Practice- Recent Graduate Presentation Erin Maynard, MD (ASTS/AHPBA) Kevin Lowe, MD (AHPBA) Ryan C. Fields, MD (SSO)

Panel Discussion Maria B. Majella Doyle, MD, MBA




— PART 3: What Do I Need to Get an HPB job? Ramanathan Seshadri MD, Erin Hanna, MD & Maria B. Majella Doyle, MD, MBA

Introduction Erin Hanna, MD

Presentations Lauren Rorabaugh (Administrative) Mark S. Talamonti, MD (Clinical)

Panel Discussion Maria B. Majella Doyle, MD, MBA & David A. Iannitti, MD

— PART 4: What kind of job Do I Want? Susanne Warner, MD & Paul Hansen, MD

If you Build It, They Will Come – key Elements of a Successful HPB Practice Paul D. Hansen, MD

Veterans Speak Hybrid Academic / Private Practice – David A. Iannitti, MD Academic – David C. Linehan, MD Private Practice – Ellen J. Hagopian, MD

Panel Discussion Paul D. Hansen, MD 10:30pm Fellows & residents Cocktail Gathering Central Bar



FridaY, FEBruAry 21, 2014

6:30am - 6:00pm aHpba registration open Ocean Tower 1 & 2 Foyer 6:30am - 5:30pm speaker ready room open San Marino 7:00am - 8:00am oral poster presentations i - setup Mona Lisa 7:00am - 8:00am Continental breakfast in exhibit Hall Pompeii/Promenade 7:00am - 2:00pm industry exhibits open Pompeii/Promenade 7:00am - 7:55am

Parallel Education Breakfast Symposium: Systemic Therapy for Pancreatic Cancer: An Update Support for this session provided by NewLink Genetics Corporation

Ocean Tower II A-B Moderator: Roderich E. Schwarz, MD, PhD

Learning By Trial: Recent Successes and Failures Roderich E. Schwarz, MD, PhD

Experience With Vaccine-Based Adjuvant Systemic Therapy John C. Mansour, MD

Future Treatment Selection Strategies Jason B. Fleming, MD




7:00am - 7:55am

Parallel Education Breakfast Symposium: NAFLD - Implications for Liver Surgery Ocean Tower 1 A-C Moderator: Srinevas Reddy, MD

Introduction Srinevas K. Reddy, MD

Epidemiology of NAFLD William R. Hutson, MD

Implications of NAFLD for Liver Surgeons Allan Tsung, MD 7:00am - 8:00am iHpba/aHpba Joint executive Meeting Executive Boardroom 8:00am - 9:00am

President’s Plenary Session Ocean Tower 1 A-C Moderator: William C. Chapman, MD pp.01. tHe near inFrared teCHniQue For CHolanGioGrapHY: 10 reasons tHat support tHe sYsteMatiC utilization oF tHe MetHod F. Dip, M. Roy, C. Simpfendorfer, E. Lo-Menzo, S. Szomstein, R. Rosenthal Cleveland Clinic Florida, Weston, FL Discussant: William R. Jarnagin, MD pp.02. in searCH oF tHe best reConstruCtive teCHniQue in tHe WHipple operation – panCreatiCoJeJunostoMY versus panCreatiCoGastrostoMY. a randoMized CliniCal trial J. Grendar, J. F. Ouellet, F. Sutherland, O. Bathe, C. Ball, E. Dixon Department Of Surgery, University Of Calgary, Calgary, ALBERTADepartment Of Surgery, Quebec City University Hospital, Quebec City, Quebec, Canada Discussant: Sean J. Mulvihill, MD




pp.03. proGnostiC role oF plasMa vasCular endotHelial GroWtH FaCtor (veGF) in patients WitH HepatoCellular CarCinoMa underGoinG liver transplantation: eXperienCe oF a sinGle Western Center W. Zhang, C. Quintini, K. Hashimoto, M. Fujiki, T. Diago, D. Kelly, B. Eghtesad, C. Miller, J. Fung, F. Aucejo Cleveland Clinic Foundation, Cleveland, OH Discussant: Jean-Nicolas Vauthey, MD pp.04. tHe eFFeCt oF preoperative renal insuFFiCienCY on postoperative outCoMes FolloWinG MaJor HepateCtoMY: a Multi-institutional analYsis oF 1170 patients M. H. Squires, N. L. Lad, S. B. Fisher, D. A. Kooby, S. M. Weber, A. S. Brinkman, C. R. Scoggins, M. E. Egger, K. Cardona, C. S. Cho, R. C. Martin, M. C. Russell, E. R. Winslow, C. A. Staley, S. K. Maithel Winship Cancer Institute, Emory University, Atlanta, GA; University Of Wisconsin, Madison, WI; University Of Louisville, Louisville, KY Discussant: Bruce D. Schirmer, MD 9:00am - 9:30am opening session Ocean Tower 1 A-C

• New Member Recognition

• HPB Certificate Completion Presentation

• Research Award & Traveling Fellowship Presentation

• 2014 Distinguished Service Award Recipient

9:30am - 10:00am presidential address: opportunities ahead for the aHpba William C. Chapman, MD Washington University Ocean Tower 1 A-C

William C. Chapman, MD Washington University Medical Center St. Louis, MO




10:00am - 10:30am Morning beverage break Pompeii/Promenade 10:30am - 11:30am

Parallel State of the Art Lecture: Anesthetic Management in Liver Surgery Support for this session provided by Edwards Lifesciences Ocean Tower 1 A-C Moderators: Mary E. Fischer, MD & William R. Jarnagin, MD

LCVP Assisted Hepatic Surgery Mary E. Fischer, MD

LCVP Assisted Laparoscopic Hepatic Surgery Chris Giordano, MD

Anesthetic Challenges for Liver Transplant Ivan Kangrga, MD

Epidural Analgesia for Hepatic Surgery Vijaja Gottumukkala, MD 10:30am - 11:30am

Parallel State of the Art Lecture: Update on Islet Cell Transplantation Ocean Tower II A- B Moderator: Christopher J. Sonnenday, MD Presenter: Rodolfo Alejandro, MD




11:45am - 1:00pm

Parallel State of the Art Lecture: ERAS in HPB Surgery Support for this session provided by Edwards Lifesciences

Ocean Tower II A-B Moderator: Thomas A. Aloia, MD

ERAS Principles Vijaya Gottumukkala, MD

Enhanced Recovery in Liver Surgery-Uk Experience O. James Garden, MD, FRCSEd

Enhanced Recovery in Pancreas Surgery Horacio J. Asbun, MD

Enhanced Recovery and Oncologic Outcomes-Moving Beyond Shorter Length of Stay Thomas A. Aloia, MD

Panel Discussion - Starting an ERAS Program in HPB Surgery 11:45am - 1:00pm

Parallel State of the Art Lecture: Downsizing of HCC Prior to Transplant Ocean Tower 1A-C Moderator: Maria B. Majella Doyle, MD, MBA

Overview of the New OPTN Criteria for HCC Milan, UCSF and Beyond Katherine Fowler, MD

Locoregional and Systemic Treatment Options to Downstage HCC Beyond Milan - What Works Best? Daniel Brown, MD

Liver Transplantation Beyond Milan Alan W. Hemming, MD




1:00pm - 2:00pm

Boxed Lunch with Exhibits & Video Presentations Support for this session provided by Ethicon, Inc. Pompeii/Promenade Moderator: Carlos U. Corvera, MD vl.01. robotiC reseCtion oF CHoledoCHal CYst WitH HepatiCoduodenostoMY S. G. Warner, K. T. Nguyen University Of Michigan, Ann Arbor, MI vl.02. robotiC seGMental duodenal reseCtion R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, D. A. Iannitti, J. B. Martinie Carolinas Medical Center, Charlotte, NC vl.03. laparosCopiC riGHt HepateCtoMY WitH HYdroJet and HarMoniC sCalpel disseCtion J. B. Conneely, R. Smoot, S. Cleary Toronto General Hospital, Tornto, Ontario, Canada

2:10pm - 2:55pm invited presidential lecturer: Hepatocellular Carcinoma: liver transplantation – the Hope for a Cure Göran B. Klintmalm, MD, PhD Baylor University Medical Center Ocean Tower 1 A-C

Invited Presidential Lecturer Göran B. Klintmalm, MD, PhD Baylor University Medical Center




2:55pm - 4:55pm

Long Oral Abstract Session A: Liver Ocean Tower 1 A-C Moderators: Clifford S. Cho, MD; Eduardo de Santibanes, MD, PhD lo-a.01. laparosCopiC HepateCtoMY siGniFiCantlY sHortens tHe tiMe to postoperative CHeMotHerapY in obese patients underGoinG MaJor HepateCtoMies S. C. Agle, P. Philips, M. E. Egger, C. R. Scoggins, K. M. McMasters, R. C. Martin, University Of Louisville, Louisville, KY lo-a.02. survival analYsis oF patients WitH staGe i and ii HepatoCellular CarCinoMa FolloWinG liver transplantation and liver reseCtion R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo, D. A. Iannitti Carolinas Medical Center, Charlotte, NC Discussant: William C. Chapman, MD lo-a.03. venous tHroMboeMboliC propHYlaXis FolloWinG HepatiC reseCtion: patterns oF Care aMonG liver surGeons M. Weiss, A. Ejaz, G. Spolverato, Y. Kim, K. Hirose, C. Wolfgang, M. Choti, T. M. Pawlik Johns Hopkins Hospital, Baltimore, MD Discussant: Michael D’Angelica, MD lo-a.04. HYpopHospHateMia aFter MaJor HepateCtoMY and tHe risK oF postoperative HepatiC insuFFiCienCY and MortalitY: an analYsis oF 719 patients M. H. Squires, G. C. Dann, N. L. Lad, S. B. Fisher, B. M. Martin, D. A. Kooby, J. M. Sarmiento, M. C. Russell, K. Cardona, C. A. Staley, S. K. Maithel Winship Cancer Institute, Emory University, Atlanta, GA; Emory University, Atlanta, GA Discussant: Peter Kingham, MD




lo-a.05. borderline operabilitY in HepateCtoMY patients is assoCiated WitH HiGHer rates oF Failure to resCue aFter severe CoMpliCations C. D. Tzeng, A. B. Cooper, S. A. Curley, J. N. Vauthey, T. A. Aloia University Of Kentucky, Lexington, KY; University of Texas MD Anderson Cancer Center, Houston, TX Discussant: Maria Russell, MD lo-a.06. renal FunCtion aFter loW Central venous pressure assisted liver reseCtion. assessMent oF 2116 Cases C. Correa-Gallego, A. Berman, S. C. Denis, V. Arslan-Carlon, T. Kingham, M. I. D Angelica, P. J. Allen, Y. Fong, R. P. DeMatteo, W. R. Jarnagin, J. Melendez, M. Fischer Memorial Sloan-Kettering Cancer Center, New York, NY Discussant: Chad Ball, MD lo-a.07. adJuvant stereotaCtiC bodY radiation FolloWinG CHeMoeMbolization iMproves survival in patients WitH non-reseCtable HepatoCellular CarCinoMa over 3 CentiMeters R. Jacob, K. Keene, F. Turley, D. T. Redden, M. K. Bryant, D. P. Dorn, L. Dover, J. White, S. H. Gray, D. E. Eckhoff, D. A. DuBay University of Alabama at Birmingham, Birmingham, AL Discussant: Paul Greig, MD lo-a.08. surGiCal ManaGeMent oF HepatiC HeManGioMas: an international Multi-institutional eXperienCe J. T. Miura, A. Li, R. Schmocker, S. Nichols, D. Sukato, E. Winslow, G. Spolverato, A. Ejaz, M. H. Squires, D. Kooby, S. Maithel, J. M. Sarmiento, M. Bloomston, K. K. Christians, F. M. Johnston, S. Tsai, K. Turaga, A. Tsung, T. Pawlik, M. Wu, T. C. Gambli Medical College Of Wisconsin, Milwaukee, WI; Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, Shanghai, China; Emory University School Of Medicine, Atlanta, GA; University Of Wisconsin School Of Medicine And Public Health, Madison, WI; The Ohio State University, Columbus, OH; Johns Hopkins University School Of Medicine, Baltimore, MD; University Of Pittsburgh School Of Medicine, Pittsburgh, PA Discussant: Susan Orloff, MD




lo-a.09. prediCtinG transplant-eliGible reCurrenCe aFter initial reseCtion oF HepatoCellular CanCer S. Lee, I. Konstantinidis , T. P. Kingham, M. I. D’Angelica, P. J. Allen, Y. Fong, R. P. DeMatteo, W. R. Jarnagin Memorial Sloan-Kettering Cancer Center, New York, NY Discussant: Maria B. Majella Doyle, MD, MBA lo-a.10. sYnCHronous priMarY ColoreCtal CanCer and liver Metastasis: iMpaCt oF operative approaCH on CliniCal outCoMes and Hospital Costs A. Ejaz, G. Spolverato, E. Semenov, D. Tanner, J. Hundt, T. M. Pawlik Johns Hopkins Hopsital, Baltimore, MD Discussant: Todd Bauer, MD 2:55pm - 4:55pm

Long Oral Abstract Session B: Pancreas Ocean Tower II A- B Moderators: Margo C. Shoup, MD; Jason Bates Fleming, MD lo-b.01. patient seleCtion and tHe voluMe eFFeCt in panCreatiC surGerY: uneQual beneFits? L. A. Bliss, C. J. Yang, K. Lagisetty, Z. Chau, S. Ng, T. S. Kent, A. J. Moser, D. W. McFadden, M. P. Callery, J. F. Tseng Beth Israel Deaconess Medical Center, Boston, MA; University Of Massachusetts Medical School, Worcester, MA; University Of Connecticut Health Center, Farmington, CT Discussant: Ching-Wei Tzeng, MD lo-b.02. reduCinG readMissions FolloWinG panCreateCtoMY: Coordination oF tHe Care ContinuuM E. P. Ceppa, H. A. Pitt, A. Nakeeb, C. M. Schmidt, N. J. Zyromski, M. G. House, B. Brand, D. Weidert, K. D. Lillemoe Indiana University School Of Medicine, Indianapolis, IN; Temple University Health System, Philadelphia, PA; Massachusetts General Hospital, Bostom, MA Discussant: Timothy Pawlik, MD, MPH, PhD




lo-b.03. patenCY rates oF portal vein/superior MesenteriC vein reConstruCtion aFter panCreateCtoMY For panCreatiC adenoCarCinoMa A. N. Krepline, K. Duelge, K. K. Christians, B. George, P. Ritch, B. Erickson, A. Mahmoud, E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gambliin, D. B. Evans, S. Tsai Medical College Of Wisconsin, Milwaukee, WI Discussant: Matthew Katz, MD lo-b.04. panCreatiC trauMa in tHe united states: a ConteMporarY appraisal B. R. Englum, A. M. Ganapathi, P. J. Speicher, J. E. Scarborough Duke University School Of Medicine, Durham, NC Discussant: Sebastian de la Fuente, MD lo-b.05. deFininG tHe postoperative MorbiditY indeX For distal panCreateCtoMY M. K. Lee, R. S. Lewis, S. Strasberg, B. L. Hall, P. Study Group, C. M. Vollmer Washington University In St. Louis School Of Medicine, St. Louis, MO; Perelman School Of Medicine, Philadelphia, PA Discussant: Michael Farnell, MD lo-b.06. tHe role oF HepatiC arterY lYMpH node Metastasis in panCreatiC CanCer: proGnostiC FaCtor or surGiCal seleCtion Criteria P. Philips, S. C. Agle, C. R. Scoggins, R. C. Martin University Of Louisville, Louisville, KY Discussant: Daniel Abbott, MD lo-b.07. propHYlaCtiC oCtreotide For panCreatoduodeneCtoMY: More HarM tHan Good? M. T. McMillan, J. D. Christein, M. P. Callery, S. W. Behrman, J. A. Drebin, T. S. Kent, B. C. Miller, R. S. Lewis, C. M. Vollmer University Of Pennsylvania, Philadelphia, PA; University Of Alabama At Birmingham Medical Center, Birmingham, AL; Beth Israel Deaconess Medical Center, Boston, MA; University Of Tennessee Health Science Center, Memphis, TN Discussant: Mark Talamonti, MD




lo-b.08. international Consensus Guideline paraMeters CarrY uneQual WeiGHt and are not CuMulative in intraduCtal papillarY MuCinous neoplasM MaliGnant risK prediCtion A. M. Roch, E. P. Ceppa, J. M. DeWitt, M. A. Al-Haddad, C. M. Schmidt Indiana University School Of Medicine, Indianapolis, IN; Indiana University Health University Hospital, Indianapolis, IN Discussant: John Martinie, MD lo-b.09. upreGulation oF s1p-reCeptor-1 in panCreatiC duCtal adenoCarCinoMa A. Cardenas, D. Cucher, T. Jie, . , R. Heimark, E. Ong University Of Arizona College Of Medicine, Tucson, AZ; University Of Arizona Cancer Center, Tucson, AZ lo-b.10. a standardized Care plan is assoCiated WitH sHorter Hospital lenGtH oF staY in patients underGoinG panCreatiCoduodeneCtoMY D. P. Nussbaum, K. Penne, P. J. Speicher, S. S. Stinnett, A. Cocieru, D. G. Blazer, S. Zani, B. M. Clary, D. S. Tyler, R. R. White Duke University School Of Medicine, Durham, NC 2:55pm - 4:55pm

Long Oral Abstract Session C: Biliary & Transplant Ocean Tower IIC Moderators: Javier C. Lendoire, MD, PhD; Oscar Cesar Imventarza, MD lo-C.01. absorbable bioprostHesis For tHe treatMent oF bile duCt inJurY in an eXperiMental Model E. E. Montalvo Javé, A. R. Jaime Limon, M. J. Kim Koh, M. A. García Pineda, B. León Mancilla, F. Rojas Mendoza , J. Tapia Jurado, C. Montalvo Arenas, J. A. Saavedra Universidad Nacional Autónoma de México, Mexico City, Mexico; Medica Sur Clinic Foundation, Mexico City, Mexico; Hospital General De México, Mexico City, Mexico




lo-C.02. national vieW on biliarY CanCer: risinG reseCtions and Considerable CoMpliCations C. J. Yang, L. A. Bliss, W. B. Al-Refaie, A. R. Evenson, K. Khwaja, S. C. Ng, J. F. Tseng Beth Israel Deaconess Medical Center, Boston, MA; MedStar Georgetown University Hospital, Washington, DC Discussant: Flavio Rocha, MD lo-C.03. is loCal reseCtion adeQuate For t1 staGe aMpullarY CanCer? A. Amini, J. Miura, T. Jayakrishnan, F. Johnston, S. Tsai, K. Christians, C. Gamblin, K. Turaga Medical College Of Wisconsin, Milwaukee, WI Discussant: Mark Bloomston, MD lo-C.04. Model to prediCt survival aFter surGiCal reseCtion oF intraHepatiC CHolanGioCarCinoMa: tHe MaYo eXperienCe S. M. Ali, C. J. Clark, T. Mounajjed, T. Wu, W. Harmsen, K. M. Reid-Lombardo, M. L. Kendrick, M. B. Farnell, D. M. Nagorney, F. Que Mayo Clinic, Rochester, MN Discussant: Timothy Pawlik, MD, MPH, PhD lo-C.06. CoMparison oF lonG terM survival betWeen liver transplantation and reseCtion in patients WitH staGe i and ii CHolanGioCarCinoMa - a national retrospeCtive analYsis R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo, D. A. Iannitti Carolinas Medical Center, Charlotte, NC Discussant: Maria B. Majella Doyle, MD, MBA lo-C.07. HepatiC arterial FloW prediCts biliarY CoMpliCations and survival in liver transplant reCipients P. T. Kim, G. Saracino, L. Jennings, M. Ramsay, G. J. McKenna, G. Testa, N. Onaca, T. L. Anthony, R. Ruiz, M. Levy, R. Goldstein, G. Klintmalm Baylor University Medical Center, Dallas, TX Discussant: William C. Chapman, MD




lo-C.08. liver transplantation is a HiGHlY eFFeCtive treatMent For ManaGeMent oF HepatoCellular CarCinoMa, even For HiGHlY seleCted advanCed staGe patients M. Doyle, N. Vachharajani, K. Fowler, K. Korenblat, J. Lowell, S. Shenoy, J. Crippin, Y. Lin, J. Wellen, N. Saad, W. Chapman Washington University School Of Medicine, St. Louis, MO lo-C.09. is liver transplantation saFe and eFFeCtive For GeriatriC (>70 Years) reCipients? a Case Controlled analYsis G. C. Wilson, R. C. Quillin, K. Wima, J. M. Sutton, D. J. Hanseman, I. M. Paquette, F. Paterno, E. S. Woodle, D. E. Abbott, S. A. Shah University Of Cincinnati, Cincinnati, OH Discussant: Christopher Anderson, MD lo-C.10. reCipient obesitY adverselY aFFeCts lonG-terM GraFt and overall survival in a sinGle institution analYsis K. D. Conzen, N. Vachharajani, K. M. Collins, C. D. Anderson, Y. Lin, J. R. Wellen, S. Shenoy, J. A. Lowell, M. Doyle, W. Chapman Washington University School of Medicine, St. Louis, MO; University Of Mississippi Medical Center, Jackson, MS Discussant: Christopher Sonneday, MD, MHS




5:00pm - 6:30pm

Oral Poster Presentations I Support for this session provided by Sirtex Medical, Inc. Mona Lisa Moderators: Ching-Wei Tzeng, MD; Michael G. House, MD Group: liver i op-i.01. Hida sCan oF tHe Flr is superior to voluMetrY to assess liver FunCtion in alpps E. Schadde, M. Lesurtel, N. Schäfer, P. Clavien University Of Zurich Hospital, Zurich, Switzerland op-i.02. MorbiditY and MortalitY in 1174 patients underGoinG HepatiC parenCHYMal transeCtion usinG a stapler deviCe M. Raoof, T. A. Aloia, J. Vauthey, S. A. Curley University Of Texas MD Anderson Cancer Center, Houston, TX; University Of Arizona, Tucson, AZ op-i.03. Mri WitH GadoXetate disodiuM For ColoreCtal liver Metastasis: is it tHe neW “Gold standard”? S. Patel, S. Cheek, H. Osman, T. Winston , D. Jeyarajah Methodist Dallas Medical, Dallas, TX op-i.04. raCial disparitY outCoMes in patients underGoinG HepateCtoMY: is renal FunCtion tHe drivinG ForCe? J. E. Dowden, D. J. Taber, J. W. McGillicuddy, C. Bratton, P. Baliga, K. D. Chavin Medical University Of South Carolina, Charleston, SC op-i.05. iMpaCt oF neo-adJuvant CHeMotHerapY on parenCHYMal sparinG in HepateCtoMY For ColoreCtal liver Metastasis S. Kaihara, K. Okada, K. Inoguchi, S. Yo, T. Yamamoto, S. Yagi, K. Uryuhara, R. Hosotani Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan




op-i.06. FallinG barriers to laparosCopiC liver reseCtion A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil, J. Buell Tulane Transplant Institute, New Orleans, LA op-i.07. tHe eFFeCt oF alCoHol on sirt1 eXpression and FunCtion in aniMal and HuMan Models oF HepatoCellular CarCinoMa K. Thompson, J. Humphries, D. J. Niemeyer, D. A. Iannitti, D. Sindram, I. McKillop Carolinas Medical Center, Charlotte, NC; University Of North Carolina At Charlotte, Charlotte, NC op-i.08. risK FaCtors For repeat CHeMoeMbolization For HepatoCellular CarCinoMa J. White, D. T. Redden, M. K. Bryant, D. P. Dorn, S. Saddekni, A. K. Aal, S. H. Gray, D. E. Eckhoff, D. A. DuBay University of Alabama at Birmingham, Birmingham, AL op-i.09. startinG a neW laparosCopiC liver surGerY proGraM: initial eXperienCe and iMproved eFFiCienCY S. Liang, S. Jayaraman University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre Toronto, Toronto, Ontario, Candad op-i.10. laparosCopiC Caudate liver reseCtion S. Lee, A. Hauch, E. Kane, E. Kandil, J. Buell Tulane Transplant Institute, New Orleans, LA

Group: liver ii op-i.11. liver reseCtion in tHe elderlY For ColoreCtal liver Metastasis: outCoMes oF oCtoGenarians E. Simoneau, M. Shaheen, A. Salman, P. Chaudhury, M. Kyres, P. Metrakos McGill University Health Center, Montreal, Quebec, Canada op-i.13. surGerY and stereotaCtiC bodY radiotHerapY (sbrt): a CoMbined approaCH For loCal Control oF liver CanCer N. L. Thai, K. Tom, A. Khan, P. Abrams, J. Oliva, A. Kirichenko, M. Szramowski Allegheny Health Network, Pittsburgh, PA




op-i.14. novel evaluation For HepatiC FunCtional reserve aFter liver reseCtion in CoMbination WitH 3d-Ct and 99MGsa sCintiGrapHY M. TANIGUCHI, A. Okizaki, K. Watanabe, K. Uchida, K. Imai, N. Shuke, H. Furukawa Asahikawa Medical University, Asahikawa, Hokkaido, Japan op-i.15. tuMor size independentlY iMpaCts survival in patients underGoinG surGerY For HepatoCellular CarCinoMa O. C. Kutlu, M. Wachtel, S. Dissanaike Texas Tech University Health Sciences Center, Lubbock, TX op-i.16. bloCKinG Cd47 proMotes pHaGoCYtosis oF HuMan HepatoCellular CarCinoMa Cells Z. Xiao, K. Ott, Y. Lin, C. Chen, L. Lin, G. Upadhya, P. Manning, W. Frazier, T. Mohanakumar , W. Chapman Washington University School Of Medicine, Saint Louis, MO; Vasculox, Inc. St Louis, Saint Louis, MO op-i.18. taCHosil® versus surGiCel® oriGinal For tHe seCondarY treatMent oF loCal bleedinG in adult patients underGoinG HepatiC reseCtion Y. Genyk, T. Kato, J. J. Pomposelli, K. W. Lophaven, W. C. Chapman, . University Of Southern California, Los Angeles, CA; Columbia University Medical Center, New York, NY; Lahey Clinic Medical Center, Burlington, MA; Takeda Development Centre Europe, Langebjerg 1, Roskilde, Denmark; Washington University School of Medicine, St. Louis, MO op-i.19. HepatiC stellate Cell-derived tenasCin-C is assoCiated WitH obesitY-induCed HepatoCellular CarCinoMa T. Li, J. H. Benbow, T. L. Walling, A. C. Smith, I. H. McKillop, D. Sindram, K. J. Thompson, L. W. Schrum Carolinas Medical Center, Charlotte, NC op-i.20. preoperative assessMent oF reMnant liver FunCtion FolloWinG HepateCtoMY bY HepatobiliarY sCintiGrapHY and indoCianine Green ClearanCe K. Okada, H. Kinoshita, Y. Sakamoto, S. Yao, T. Yamamoto, K. Inoguchi, R. Hosotani, S. Kaihara Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan




Group: panCreas i op-i.21. CHaraCterization oF panCreatiCo-enteriC anastoMotiC HealinG in a porCine survival Model Y. S. Khajanchee, W. Johnston, C. B. Bifulco, M. A. Cassera, C. W. Hammill, P. D. Hansen Providence Portland Cancer Center, Portland, OR op-i.22. preoperative neutropHil-to-lYMpHoCYte ratio (nlr) and seruM Ca19-9 as siGniFiCant prediCtors For panCreatiC Head CanCer T. Asaoka, A. Miyamoto, K. Yamamoto, N. Haraguchi, M. Miyake, K. Nishikawa, M. Hirao, M. Ikeda, M. Sekimoto, S. Nakamori Osaka National Hospital, Osaka, Osaka, Japan op-i.24. use oF Gland and tuMor CHaraCteristiCs and preoperative Ct sCans to prediCt panCreatiC Fistula aFter distal panCreateCtoMY C. Johnston, L. Harmon, L. Haykin, J. Shen, H. Hahn, D. Coy, M. Lasarev, C. Mathews, M. Cassera, M. Brown, R. Wolf, P. Hansen, C. Hammill, A. Alseidi, P. Newell Providence Portland Cancer Center, Portland, OR; Virginia Mason Medical Center, Seattle, WA; Oregon Health and Science University, Portland, OR op-i.25. HiGHer lYMpH node ratio prediCts earlY reCurrenCe aFter Curative reseCtion For panCreatiC adenoCarCinoMa E. W. Gilbert, N. W. Bronson, T. Kaur, K. Billingsley, B. C. Sheppard Oregon Health and Science University, Portland, OR op-i.26. sinGle-institution eXperienCe WitH reseCtion oF side-branCH ipMn: a revieW oF pre-operative CHaraCteristiCs and Final patHoloGiC diaGnosis J. D. Dortch, J. A. Stauffer, H. J. Asbun Mayo Clinic-Florida, Jacksonville, FL op-i.27. panCreatiC CanCer MetastatiC to a liMited nuMber oF lYMpH nodes does not adverselY aFFeCt outCoMe M. Kukar, S. W. Badwin, K. Attwood, N. Wilkinson, S. N. Hochwald, B. Kuvshinoff II Roswell Park Cancer Institute, Buffalo, NY




op-i.28. variations in MediCal onColoGY utilization praCtiCes bY panCreatiC CanCer patients in a sinGle paYer HealtH Care sYsteM S. Hurton, G. Porter, M. Walsh, M. Molinari Dalhousie University, Halifax, Nova Scotia, Canada; Cancer Care Nova Scotia, Halifax, Nova Scotia, Canada op-i.29. lonG terM outCoMes Favor pYlorus preservinG panCreatiCoduodeneCtoMY over duodenuM preservinG panCreatiC Head reseCtion For CHroniC panCreatitis: a Meta-analYsis and sYsteMatiC revieW P. B. Sukharamwala, S. B. Ross, S. Parikh, C. E. Ryan, T. W. Wood, A. S. Rosemurgy Florida Hospital Tampa, Tampa, FL; American University Of Antigua, New York, NY

Group: panCreas ii op-i.30. neoadJuvant CHeMoradiation deCreases lYMpH node ratio in borderline reseCtable panCreatiC duCtal adenoCarCinoMa J. S. Peng, N. Ali, G. Falk, D. Joyce, C. O’Rourke, J. McMichael, J. Wey, S. Chalikonda, K. M. El-Hayek, R. M. Walsh Cleveland Clinic Foundation, Cleveland, OH op-i.31. delaYed GastriC eMptYinG FolloWinG panCreatiCoduodeneCtoMY: inCidenCe, risK FaCtors, and HealtHCare utilization S. Mohammed, G. Van Buren, A. McElhany, M. Issazadeh, E. J. Silberfein, D. A. Anaya, S. E. Hodges, W. E. Fisher Baylor College Of Medicine, Houston, TX; Elkins Pancreas Center, Houston, TX op-i.32. portal vein reseCtion is assoCiated WitH iMproved survival aFter panCreatiCoduodeneCtoMY For panCreatiC CanCer P. B. Sukharamwala, K. D. Patel, R. L. Klein, T. W. Wood, A. F. Teta, A. S. Rosemurgy Florida Hospital Tampa, Tampa, FL




op-i.34. role oF surGiCal palliation in patients WitH panCreatiC duCtal adenoCarCinoMa (pdaC) A. Abbasi, R. Lo, A. J. Moser, J. F. Tseng, C. M. Vollmer, M. P. Callery, T. S. Kent Beth Israel Deaconess Medical Center Boston, MA; University Of Pennsylvania, Philadelphia, PA op-i.35. propHYlaCtiC antiCoaGulation For superior MesenteriC vein (sMv) or portal vein (pv) narroWinG/oCClusion in borderline reseCtable (blr) panCreatiC adenoCarCinoMa (pC) patients A. N. Krepline, K. Duelge, B. George, P. Ritch, B. A. Erickson, A. Mahmoud, E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gamblin, K. K. Christians, D. B. Evans, S. Tsai Medical College Of Wisconsin, Milwaukee, WI op-i.36. reGionalization oF Hepato-panCreato-biliarY CanCer treatMent WitHin tHe state oF Florida aCCordinG to tHe aMeriCan ColleGe oF surGeons CoMMission on CanCer aCCreditation N. Agee, P. Veldhuis , S. Eubanks, P. Arnoletti, S. G. De La Fuente Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL op-i.37. obesitY is not assoCiated WitH panCreatiC CarCinoMa or inpatient MortalitY aFter panCreatiC reseCtion E. S. Glazer, E. S. Ong The University Of Arizona, Tucson, AZ op-i.38. panCreatoduodeneCtoMies in ColoMbia: a Qualitative studY oF tHe panCreatiC surGerY FroM tHe surGeons’ perspeCtive J. Sabogal Olarte, C. G. Ball, F. Sutherland, O. Bathe, E. Dixon Foothills Medical Centre-University Of Calgary, Calgary, Alberta, Canada




Group: transplant/otHer op-i.40. panCreas transplantation outCoMes diFFer based on aGe GroupinGs: an analYsis oF tHe unos database E. Siskind, C. Maloney, M. Akerman, A. Shen, A. Basu, E. Molmenti, J. Ortiz, North Shore Long Island Jewish Health System, Manhasset, NY; Albert Einstein Medical Center, Philadelphia, PA op-i.42. interventional radioloGY stentinG and tpa For HepatiC arterY tHroMbosis in liver transplantation revisited: a False Hope WitH FreQuent need For retransplantation C. W. Michalski, J. Pasko, K. Roayaie, D. L. Scott, S. L. Orloff Oregon Health and Science University, Portland, OR op-i.43. Hpb surGerY FroM sCratCH: a sinGle surGeon’s one Year eXperienCe in establisHinG a HiGH voluMe Hpb Center J. S. Cardinal, S. Cho West Virginia University, Morgantown, WV op-i.44. surGerY to tHe eXtreMe: tHe ConCept oF “transplant onColoGY” T. Hibi, Y. Abe, O. Itano, H. Obara, M. Shinoda, M. Kitago, H. Yagi, Y. Kitagawa Keio University School Of Medicine, Tokyo, Japan op-i.45. aMpullarY and eXtra-aMpullarY duodenal adenoCarCinoMas Have CoMparable survival aFter potentiallY Curative reseCtion K. H. Dinh, V. Bathini, B. Switzer, V. Kasturi, W. Wassef, J. Zivny, M. Sullivan, G. Whalen, J. LaFemina University Of Massachusetts Medical School, Worcester, MA op-i.46. tips is not neCessarY For tHe suCCessFul ManaGeMent oF ruptured parauMbiliCal Hernias in patients WitH advanCed HepatiC CirrHosis and reFraCtorY asCites N. A. Chatzizacharias, J. A. Bradley, E. Huguet, A. Jah, N. V. Jamieson, R. K. Praseedom, P. Gibbs Addenbrooke’s University Hospital, Cambridge, United Kingdom




op-i.47. a Multi-deteCtor Ct analYsis oF tHe abdoMinal Wall struCture around tHe uMbiliCus WitH speCial reFerenCe to tHe deHisCenCe oF tHe linea alba: Could it be an under-reCoGnized predisposinG FaCtor For adult uMbiliCal Hernia? A. Shimizu, U. Mitsuhashi, M. Tanaka, Y. Yasuda Koganei Central Hospital, Shimotsuke, Tochigi, Japan; Jichi Medical University, Shimotsuke, Tochig, Japan i 5:00pm - 7:15pm industry exhibits open Pompeii/Promenade 6:30pm - 7:15pm Cocktail reception in exhibit Hall & Highlighted videos Support for this session provided by Ethicon, Inc. Pompeii/Promenade Moderator: Horacio J. Asbun, MD and Thomas A. Aloia, MD vr.01. laparosCopiC repair oF erCp related duodenal perForation R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, J. J. Lewis, D. Sindram, J. B. Martinie, D. A. Iannitti Carolinas Medical Center, Charlotte, NC vr.02. KlatsKin tuMor: leFt HepateCtoMY WitH Caudate lobe reseCtion usinG leFt HanGinG Maneuver R. Sanchez Claria, n. Resio, o. Mazza, f. Alvarez, M. de Santibañes, S. Bilbao Hospital Italiano Buenos Aires, Capital Federal, Buenos Aires, Argentina vr.03. robotiC assisted CYst GastrostoMY and eXCision oF a panCreatiC pseudoCYst eXtendinG to tHe pelvis T. K. Nguyen, A. H. Zureikat University Of Pittsburgh Department Of Surgery, Pittsburgh, PA




6:30pm oral poster presentations i - teardown Mona Lisa 7:15pm - 10:30pm Congress banquet Ocean Garden (Rain Backup: Ocean Tower II A-C)



6:15am - 7:30am aHpba Foundation Fund run Meet at Spa Entrance Fee: $50 per person 6:30am - 7:45am oral poster presentations ii - setup Mona Lisa 7:00am - 6:00pm aHpba registration open Ocean Tower 1 & 2 Foyer 7:00am - 6:00pm speaker ready room open San Marino 7:00am - 6:00pm saGes Working Group Executive Board Room 7:00am - 8:00am Continental breakfast in exhibit Hall Pompeii/Promenade 7:00am - 11:15am industry exhibits open Pompeii/Promenade

saturdaY, FEBruAry 22, 2014



7:00am - 8:00am

Parallel Long Abstracts D: Tricks of the Trade Ocean Tower II A- B Moderators: Conrad H. Simpfendorfer, MD; Nicolas P. Jarufe Casis, MD lo-d.01. splenopneuMopeXY: deCoMpression oF portal HYpertension in tHe settinG oF portal venous oCClusive disease J. M. Sutton, S. L. Starnes, S. A. Shah University Of Cincinnati Medical Center, Cincinnati, OH Discussant: Alan Heming, MD, MSC lo-d.02. earlY vein reConstruCtion and riGHt-to-leFt panCreatiC disseCtion For leFt sided panCreatiC tuMors WitH pv/sMv oCClusion J. M. Cloyd, B. C. Visser Stanford University, Stanford, CA Discussant: Susan Logan, MD lo-d.03. laparosCopiC eXposure and liGation oF tHe riGHt branCH oF tHe portal vein S. Jayaraman University Of Toronto, Toronto, Ontario, Canada Discussant: Paul Hansen, MD lo-d.04. laparosCopiC liver Mobilization – triCKs oF tHe trade to avoid CoMpliCations N. Ikoma, G. Oshima, O. Itano University Of Texas Health Science Center At Houston, Houston, TXKeio University School Of Medicine, Tokyo, Tokyo, Japan Discussant: Hiromichi Ito, MD lo-d.05. transGastriC panCreatiC neCroseCtoMY - triCKs oF tHe trade N. J. Zyromski Indiana University Department Of Surgery, Indianapolis, IN




7:00am - 8:00am

Parallel Long Abstracts E: Video Presentations Support for this session provided by Ethicon, Inc. Pompeii/Promenade Moderators: Courtney Scaife, MD; Derek A. Dubay, MD lo-e.01. seGMent viii reseCtion For Colon CanCer Metastasis usinG tHe in situ Cold perFusion teCHniQue WitH riGHt and Middle HepatiC vein reConstruCtion M. Segedi, I. McGilvray, P. Greig, P. Kelly, A. Fung, G. Tait, University Of Toronto, Toronto, Ontario, Canada lo-e.02. totallY laparosCopiC Caudate lobeCtoMY WitH partial Caval reseCtion C. U. Corvera, C. A. Galanopolus, A. Farzad, V. Kuo University Of California San Francisco, San Francisco, CA lo-e.03. ante situM HepateCtoMY and replaCeMent oF inFerior vena Cava and HepatiC vein usinG a transitorY porto-Caval sHunt A. Yanzon, A. Cristiano, L. Yazde, F. Rodriguez Santos, M. de Santibañes, J. Pekolj, E. de Santibañes Hospital Italiano de Buenos Aires, Ciudad Autonoma De Buenos Aires, Argentina lo-e.04. robotiC panCreatiCoduodeneCtoMY WitH anoMalous HepatiC arterial anatoMY A. H. Zureikat, T. K. Nguyen, H. J. Zeh University Of Pittsburgh Department Of Surgery, Pittsburgh, PA lo-e.05. intraoperative use oF GooGle Glass For Hepato-panCreato-biliarY surGerY S. L. Bokshan, W. Chapman, M. Doyle Washington University School Of Medicine, St. Louis, MO; BJC Health System, St. Louis, MO




7:00am - 8:00am

Parallel Long Abstracts F: Other Ocean Tower IIC Moderators: Nestor A. Gomez, MD LO-F.01. DEVELOPMENT OF AN INTERNATIONAL ONLINE LEARNING PLATFORM FOR HPB TRAINING – A NEEDS ASSESSMENT S. G. Warner, S. J. Connor, C. Christophi, I. Azodo, T. S. Kent, D. Pier, R. M. Minter University Of Michigan, Ann Arbor, MI; Christchurch Hospital, Christchurch, New Zealand; University Of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia; Royal Infirmary Of Edinburgh, Edinburgh, Scotland; Beth Isreal Deaconess Medical Center, Boston, MA LO-F.02. THE CURRENT STATE OF HPB FELLOWSHIP EXPERIENCE IN NORTH AMERICA H. Osman, D. Jeyarajah Methodist Dallas Medical Center, Dallas, TX Discussant: W. Scott Helton, MD LO-F.03. SURGICAL MANAGEMENT OF METASTATIC COLON CANCER IN ELDERLY: ANALYSIS OF THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) DATABASE. H. Khan, A. Olszewski, P. Somasundar Roger Williams Medical Center, Providence, RI; Pawtucket Memorial Hospital, Pawtucket, RI Discussant: Nestor Gomez, MD LO-F.04. INTRA-OPERATIVE LIVER BIOPSY PATHOLOGY IN PATIENTS UNDERGOING WEIGHT LOSS SURGERY A. Dan, M. Subichin, J. Clanton, M. Makuszewski, A. Bohon, M. Pozsgay, R. Shenoy, S. M. Thompson, A. Venkataramani, C. Sievers, J. Zografakis Summa Health System, Akron, OH; Northeast Ohio Medical University, Rootstown, OH Discussant: Conrad Simpfendorfer, MD LO-F.05. SURGICAL AND TOTAL COSTS OF HEPATO-PANCREATO-BILIARY (HPB) SURGERY FOR US PATIENTS ENROLLED IN PRIVATE INSURANCE J. R. Schubart, E. Schaefer, A. N. Kulaylat, C. S. Hollenbeak, N. J. Gusani Penn State College Of Medicine, Hershey, PA

SATURDAY, FEBRUARY 22, 2014


8:00am - 9:15am

Parallel Symposium II: Clinical Trials in Progress I: HB Ocean Tower II A-B Moderator: Sharon Weber, MD; Shishir K. Mathel, MD

1. Sequential TACE + PVE vs PVE Alone Before Major Hepatectomy

For Patients With Hepatocellular Carcinoma: A Randomised Control

Wong-Hoi She

The University Of Hong Kong, Hong Kong

2. A Phase II Clinical Trial Of Bavituximab And Sorafenib In Patients

With Advanced Hepatocellular Carcinoma (HCC)

Adam Yopp, MD

University of Texas Southwestern Medical Center, Dallas, TX

3. A Phase II Randomized Multicenter Placebo-Controlled Study of

Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant

(OLT) Recipients with Hepatocellular Carcinoma (HCC)

Fady Kaldas, MD

University of California Los Angeles, Los Angeles, CA

4. Phase IB/II Study of Pasireotide, Everolimus, and Selective Internal

Radioembolization Therapy (SIRT) for Unresectable Neuroendocrine

Hepatic Metastases

Malcolm H. Squires, MD

Winship Cancer Institute, Emory University, Atlanta, GA

5. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic

Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine

and Cisplatin (Gem-Cis)

Robert CG Martin, II, MD, PhD

University of Louisville, Louisville, KY

6. Multicentre Evaluation of a Novel Technique of Analgesia Following Open

Liver Resection: Medial Open Transversus Abdominis Plane

Paul J Karanicolas, MD

University of Toronto, Toronto, Ontario, Canada


7. A Pilot Study to Optimize Imaging When Utilizing the PINPOINT Endoscopic Fluorescence Imaging System for Identification of Biliary Anatomy During Laparoscopic Biliary and Hepatic OperationsAli Zarrinpar, MDUCLA

(MOTAP) Catheters


8:00am - 9:15am

Parallel Symposium II: Screening for Pancreatic Cancer Ocean Tower 1 A-C Moderator: Rebekah White, MD

Who to Screen? Risk Factors for Pancreatic Cancer Rebekah White, MD

How to Screen? Screening Modalities Christopher Wolfgang, MD

Whether to Screen? Risk Models and Effectiveness Steven Gallinger, MD

9:15am - 10:00am leslie H. blumgart Historical lecture: a Historical Journey through variceal bleeding J. Michael Henderson, MD Cleveland Clinic Ocean Tower 1 A-C

10:00am - 10:45am

Parallel Update Lecture: just When you Thought you Understood Medicare Payment Ocean Tower II A-B Moderator: Bryan A. Clary, MD

ACS Update on Medicare payment Andrew L. Warshaw, MD


Leslie H. Blumgart Historical Lecturer J. Michael Henderson, MD Cleveland Clinic Cleveland, OH



10:00am - 10:45am

Parallel Update Lecture: ALPPS - An Update Ocean Tower 1 A-C Moderator: Shimul A. Shah, MD

Updates Pierre-Alain Clavien, MD, PhD 10:45am - 11:15am

Morning Beverage Break & Video Presentations Support for this session provided by Ethicon, Inc. Pompeii/Promenade Moderators: Sharona Ross, MD; Jeffrey S. Barkun, MD vb.01. robotiC-assisted panCreatoduodeneCtoMY For CanCer E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares, R. Caruso, R. Ceron, J. Plaza Sanchinarro University Hospital, Madrid, Spain vb.02. sYnCHronous total laparosCopiC riGHt HepateCtoMY and riGHt HeMiColeCtoMY S. Jayaraman University Of Toronto, Toronto, Ontario, Canada vb.03. near inFrarred teCHnoloGY Gives a neW tool to tHe surGeons to identiFY biliarY anatoMY F. Dip, M. Roy, C. Simpfendorfer, E. Lomenzo, S. Szomstein, R. Rosenthal Cleveland Clinic Florida, Weston, FL 11:15am - 12Noon

Parallel Debates I: RFA for Colorectal Mets: Routine or Second Line? Ocean Tower II A-B Moderator: Sean P. Cleary, MD

Introduction and Case Presentation Sean P. Cleary, MD

Pro: Allan E. Siperstein, MD Con: Octavio Gil, MD




11:15am - 12Noon

Parallel Debates I: MIS Whipple - Viable Options in Today’s Economic Climate Ocean Tower 1 A-C Moderator: Charles M. Vollmer, MD Presenters: C. Max Schmidt, MD; W. Scott Helton, MD 12Noon - 1:00pm

State of the Art Lecture: Update on Intrahepatic Cholangiocarcinoma Ocean Tower 1 A-C Moderator: Flavio Rocha, MD Presenters: Timothy M. Pawlik, MD, PhD & William R. Jarnagin, MD

12Noon - 1:00pm

State of the Art Lecture: Molecular Markers in the Prognosis of HPB Malignancies Ocean Tower II C Moderator: Ryan C. Fields, MD

Manipulating the Tumor Microenvironment in Pancreas Cancer to Improve Outcomes David E. Linehan, MD

Emerging Role of RAS Mutations in Colorectal Liver Metastases Jean-Nicolas Vauthey, MD 1:00pm - 2:00pm

Parallel Educational Lunch Symposia - Difficult Cases in HPB Ocean Tower II A-B Moderators: Pamela Hodul, MD & Margo Shoup, MD Panelists: Sharon M. Weber, MD Kaye M. Reid Lombardo, MD Gabriel E. Gondolesi, MD




1:00pm - 2:00pm

Parallel Educational Lunch Symposia - Spanish Session Ocean Tower 1 A-C Moderators: Sebastian de la Fuente, MD & Javier Lendoire, MD, PhD

Manejo Laparoscópico de patología pancreática benigna (Laparoscopic management of benign pancreatic disease) Nicolas D. Jarufe Cassis, MD

Lesiones de vías biliares (Management of bile duct injuries) Miguel Angel Mercado, MD

Hepatectomias laparoscópicas en América Latina (Laparoscopic hepatic resections in Latin America) Rodrigo Sanchez Claria, MD 2:30pm - 5:30pm

Parallel Oral Abstracts G: Liver / Other Ocean Tower 1 A-C Moderators: Ajay V. Maker, MD; Paul D. Greig, MD o-G.01. earlY identiFiCation oF patients at inCreased risK For HepatiC insuFFiCienCY, CoMpliCations, and MortalitY aFter MaJor HepateCtoMY J. W. Etra, M. H. Squires, S. B. Fisher, D. R. Rutz, B. Martin, D. A. Kooby, K. Cardona, J. M. Sarmiento, C. A. Staley, S. K. Maithel, M. C. Russell Winship Cancer Institute, Emory University, Atlanta, GA Discussant: Paxton Dickson, MD o-G.02. eFFeCt oF obesitY on perioperative outCoMes FolloWinG laparosCopiC HepateCtoMY S. Lee, A. Hauch, E. Kane, E. Kandil, J. Buell Tulane Transplant Institute, New Orleans, LA




O-G.03. MORTALITY IN HEPATECTOMY: MODEL FOR END-STAGE LIVER DISEASE (MELD) AS A PREDICTOR FOR DEATH USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) S. W. Ross, B. Oommen, M. Kim, V. A. Augenstein, A. L. Walter, B. T. Heniford, D. A. Iannitti, J. B. Martinie, R. Z. Swan Carolinas Medical Center, Charlotte, NC Discussant: Joseph Buell, MD O-G.04. ENUCLEATION OF HEPATIC NEUROENDOCRINE TUMOR METASTASES: A VALUABLE ADJUNCT TO SURGICAL CYTOREDUCTION N. N. Nissen, V. G. Menon, E. M. Wolin, R. Yu, S. D. Colquhoun Cedars-Sinai Medical Center, Los Angeles, CA O-G.05. EXPRESSION LEVELS OF INSULIN-LIKE GROWTH FACTORS AND RECEPTORS IN HEPATOCELLULAR CARCINOMA Y. S. Chun, M. Huang, L. Rink Virginia Piper Cancer Institute, Minneapolis, MN; Fox Chase Cancer Center, Philadelphia, PA Discussant: Roderich Schwarz, MD O-G.06. POSITIVE CROSSMATCH AND THE ROLE OF DONOR SPECIFIC ANTIBODY IN LIVER TRANSPLANTATION R. J. Lynch, N. Lysak, S. Perez, T. Roberts-Wilson, R. A. Bray, H. M. Gebel, S. J. Knechtle Emory Transplant Center, Atlanta, GA

O-G.08. INTRAOPERATIVE ULTRASOUND DURING RESECTION OF COLORECTAL LIVER METASTASES: IMPACT ON DETECTION OF LESIONS, CHANGE IN SURGICAL STRATEGY AND ACHIEVEMENT OF NEGATIVE RESECTION MARGINS S. A. Knowles, K. P. Croome, R. Hernandez-Alejandro University Of Western Ontario, London Health Science Centre, London, Ontario, Canada; Mayo Clinic, Rochester, MN Discussant: Timothy Pawlik, MD, MPH, PhD


O-G.07. FINANCIAL BENEFITS OF A HEPATOPANCREATICOBILIARY (HPB) PROGRAMS. B. Ross, R.L. Klein, C.E. Ryan, T.W. Wood, P.B. Sukharamwala, A.S. RosemurgyFlorida Hospital Tampa, Tampa, FL


o-G.09. non-invasive prediCtion oF sinusoidal inJurY in patients treated WitH oXaliplatin For ColoreCtal liver Metastases. J. Urdzik, T. Bjerner, A. Wanders, F. F. Duraj, U. Haglund, A. Norén Uppsala University, Uppsala, Sweden o-G.10. patient and tuMor bioloGY prediCt survival beYond tHe Milan Criteria in liver transplantation For HepatoCellular CarCinoMa A. Andreou, P. Neuhaus, D. Seehofer Charité Campus Virchow Klinikum, Berlin, Germany Discussant: Maria B. Majella Doyle, MD, MBA o-G.11. a 20 Year revieW oF liver transplantation: CHanGinG indiCations over 2 deCades M. Doyle, N. Vachharajani, J. A. Lowell, S. Shenoy, J. R. Wellen , Y. Lin, W. C. Chapman Washington University School Of Medicine, St. Louis, MO o-G.12. a siMpliFed FrailtY indeX to aCCuratelY prediCt MorbiditY and MortalitY aFter HepatiC reseCtion L. M. Louwers, G. Schnickel, I. Rubinfeld Henry Ford Health System, Detroit, MI Discussant: Ali Zarrinpar, MD o-G.13. assoCiatinG liver partition and portal vein liGation For staGed HepateCtoMY (alpps) versus portal vein eMbolization in tHe ManaGeMent oF ColoreCtal liver Metastases K. P. Croome, R. Hernandez-Alejandro University Of Western Ontario, London Health Science Centre, London, Ontario, Canada; Mayo Clinic, Rochester, MN Discussant: W. Scott Helton, MD




o-G.14. CoMparison oF survival and tolerabilitY oF liver radioeMbolization in elderlY vs. YounGer patients WitH MetastatiC ColoreCtal CanCer S. Tohme, G. Nace, D. Sukato, J. Steele, A. Zajko, N. Amesur, J. W. Marsh, D. Geller, A. Tsung University Of Pittsburgh School Of Medicine, Pittsburgh, PA Discussant: Clifford Cho, MD o-G.15. WHat is tHe Current role oF periHepatiC drain (pd) plaCeMent in liver surGerY? a prospeCtive analYsis J. M. Butte, J. Grendar, O. Bathe, F. Sutherland, C. G. Ball, E. Dixon Foothills Medical Centre-University Of Calgary, Calgary, Alberta, Canada Discussant: Andrew McKay, MD, BSc, MSc 2:30pm - 5:30pm

Parallel Oral Abstracts H: Pancreas / Transplant / Biliary Ocean Tower II A-B Moderators: Christopher D. Anderson, MD; Juan Francisco Guerra, MD o-H.01. panCreatiC Fistulas aFter panCreatiCo- duodeneCtoMies: are panCreatiCo-GastrostoMies saFer tHan panCreatiCoJeJunostoMies ? a Quasi-eXperiMent and propensitY-sCore adJusted analYsis J. Abou Khalil, S. Dumitra, M. Jamal, N. Mayo, P. Chaudhury, P. Metrakos, J. Barkun McGill University Health Center, Montreal, Quebec, Canada Discussant: Charles Vollmer, MD o-H.02. a novel onColYtiC adenovirus tarGetinG C-Met reCeptor inCreases inFeCtivitY eFFiCienCY and onColYtiC aCtivitY in HuMan panCreatiC adenoCarCinoMa Cell lines Q. D. Chu, G. Sun, L. Liu, B. Li, R. H. Kim, J. M. Mathis Louisiana State University Health Sciences Center-Shreveport, Shreveport, LOUISIANA Discussant: Nipun Merchant, MD




o-H.03. neoadJuvant FolFirinoX appliCation in borderline reseCtable panCreatiC adenoCarCinoMa. A. Paniccia, B. Edil, R. Schulick, C. Gajdos, J. T. Byers, C. Meguid, M. McCarter University Of Colorado Hospital, Aurora, CO Discussant: Christopher Wolfgang, MD o-H.04. perioperative risK FaCtors For delaYed GastriC eMptYinG in panCreatiCoduodeneCtoMY J. R. Robinson, P. Marincola, J. Shelton, N. Merchant, K. Idrees, A. Parikh Vanderbilt University Medical Center, Nashville, TN Discussant: Daniel Abbott, MD o-H.05. Cost CoMparison analYsis oF open vs. laparosCopiC distal panCreateCtoMY D. R. Rutz, M. H. Squires, S. K. Maithel, J. M. Sarmiento, J. W. Etra, S. D. Perez, W. Knechtle, K. Cardona, M. C. Russell, C. A. Staley, J. F. Sweeney, D. A. Kooby Winship Cancer Institute, Emory University, Atlanta, GA Discussant: Michael D’Angelica, MD o-H.06. Failure oF narCotiC Wean aFter total panCreateCtoMY WitH islet autotransplantation K. A. Morgan, S. M. Owczarski, H. Wang, W. Balliet, J. J. Borckardt, D. B. Adams Medical University Of South Carolina, Charleston, SC Discussant: Syed Ahmad, MD o-H.07. risK FaCtors For developMent oF steatosis and steatoHepatitis aFter panCreatiCoduodeneCtoMY L. K. Fonkoua, R. Tappouni, N. H. Bhayani, E. T. Kimchi, K. F. Staveley-O’Carroll, J. T. Kaifi, N. J. Gusani Penn State College Of Medicine, Hershey, PA




o-H.08. Case ContaMination reportinG in Hpb surGerY: Can a sinGle Word CHanGe publiC perCeption oF institutional perForManCe? P. J. Speicher, D. Nussbaum, J. E. Scarborough, R. R. White, C. R. Mantyh, D. S. Tyler, B. M. Clary Duke University School Of Medicine, Durham, NC o-H.09. tarGeted inHibition oF tHe aKt patHWaY in CHolanGioCarCinoMa bY MK2206 J. M. Wilson, S. Kunnimalaiyaan, M. Kunnimalaiyaan, T. Gamblin Medical College Of Wisconsin, Milwaukee, WI o-H.10. are General surGerY residents adeQuatelY prepared For HepatopanCreatiCobiliarY (Hpb) FelloWsHips? Questionnaire based studY H. Osman, J. Parikh, S. Patel, D. Jeyarajah Methodist Dallas Medical Center, Dallas, TX; Indiana University Hospital, Indianapolis, IN Discussant: Paul D. Hansen, MD o-H.11. portal venous sYsteM deCoMpressive proCedures durinG panCreatiC reseCtion: perioperative and lonG-terM outCoMes M. J. Truty, R. M. Thomas, J. E. Lee, M. H. Katz, J. B. Fleming Mayo Clinic College Of Medicine, Rochester, MN; University Of Texas MD Anderson Cancer Center, Houston, TX; University Of Florida College Of Medicine, Gainseville, FL o-H.12. Cost-eFFeCtiveness aFter panCreatiCoduodeneCtoMY: bolsterinG tHe voluMe arGuMent J. M. Sutton, G. C. Wilson, K. Wima, R. C. Quillin, I. M. Paquette, D. J. Hanseman, J. J. Sussman, M. J. Edwards, S. A. Ahmad, S. A. Shah, D. E. Abbott University Of Cincinnati Medical Center, Cincinnati, OH Discussant: David Kooby, MD




o-H.13. panCreatiCoduodeneCtoMY in Florida: do 20 Year trends doCuMent salutarY beneFits oF Centralization oF Care? T. W. Wood, S. B. Ross, A. E. Smart, C. E. Ryan, P. B. Sukharamwala, A. S. Rosemurgy Florida Hospital Tampa, Tampa, FL Discussant: Mark Bloomston, MD o-H.14. aJCC staGinG For reseCted Hilar CHolanGioCarCinoMa: 7tH edition better tHan 6tH, but not an independent proGnostiC FaCtor B. Groot Koerkamp, J. K. Wiggers, P. J. Allen, O. R. Busch, M. I. D’Angelica, R. P. Dematteo, Y. Fong, D. J. Gouma, T. P. Kingham, T. M. Van Gulik, W. R. Jarnagin Memorial Sloan-Kettering Cancer Center, New York, NY; Academic Medical Center Amsterdam, Amsterdam, Noord-Holland Discussant: David Kooby, MD o-H.15. HiGH-voluMe surGeons versus HiGH-voluMe Hospitals: are best outCoMes More due to WHo or WHere? P. G. Toomey, S. B. Ross, A. N. Igartua, M. DeGori, A. F. Teta, K. Luberice, P. B. Sukharamwala, A. S. Rosemurgy Florida Hospital Tampa, Tampa, FL; University Of South Florida, Tampa, FL Discussant: Sharon Weber, MD 2:30pm - 4:00pm

Clinical Trials in Progress II: Pancreas Ocean Tower II C Moderator: John C. Mansour, MD; Adam Yopp, MD

1. Randomized Phase II Trial of Pre-Operative Gemcitabine and nab-Paclitacel with or with out the Autophagy Inhibitor Hydroxychloroquine In Pancreatic Adenocarcinoma Herbert J. Zeh, MD University of Pittsburgh, Pittsburgh, PA

2. A MultiCenter Mayo Initiated Prospective Randomized Controlled trial to Comparing Pancreatic Leaks after TissueLink vs SeamGuard After Distal Pancreatectomy (PLATS) Florencia G Que, MD Mayo Clinic, Rochster, MN




3. Neoadjuvant Folfirinox and Chemoradiation Followed by Definitive Surgery and Postoperative Gemcitabine for Patients with Borderline Resectable Pancreatic Adenocarcinoma: An Intergroup Single-Arm, Phase II Trial Syed A. Ahmad, MD The University of Cincinnati, Cincinatti, OH

4. Evaluation of the Novel Imaging Modality Simultaneous Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Patients with Pancreatic Adenocarcinoma Ryan C. Fields, MD Washington University School of Medicine, St. Louis, MO

5. Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of Excision Repair Cross-Complementing Gene-1 (ERCC1) in Treatment Decisions Malcolm H. Squires, MD Winship Cancer Institute, Emory University, Atlanta, GA

7. A Randomized Prospective Multicenter Trial of Pancreatic Resection with and without Routine Intraperitoneal Drainage William E. Fisher, MD Baylor College of Medicine, Houston, TX

8. FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Dominic E. Sanford, MD Washington University School of Medicine, St. Louis, MO


6. Phase I Trial of Chemoimmunotherapy and Hypofractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaPippa NewellProvidence Cancer Center, Portland, OR


4:00pm - 5:30pm

Surgical Innovation Committee Symposium Simulation: Transforming the Training, Techniques and Safety of HPB Surgery Support for this session provided by Intuitive Surgical Ocean Tower II C Moderator: A. James Moser, MD

Preoperative and Intraoperative Use of Virtual & Augmented Reality Technologies: Patient-Specific Simulation Professor Luc Soler

Surgical Simulation, Validated Assessment and the Drive to Enhance Patient Safety in Minimally Invasive Surgery L. Michael Brunt, MD

Radical Curricular Reform: New Concepts in Training Richard K. Reznick, MD, MEd 5:30pm - 6:30pm aHpba business Meeting (members only) Ocean Tower I A-C 6:15pm - 7:45pm

Oral Poster Presentations II Mona Lisa Moderators: Quyen D. Chu, MD, MBA; Martin Palavecino, MD Group: liver iii op-ii.01. eXpression oF FattY aCid bindinG proteins in a Mouse Model oF obesitY-assoCiated HCC K. J. Thompson, S. S. Nazari, D. A. Iannitti, I. H. McKillop, D. Sindram Carolinas Medical Center, Charlotte, NC




op-ii.02. survival FolloWinG MultidisCiplinarY ManaGeMent oF eXtensive ColoreCtal liver Metastases J. Pasko, J. Wagner, O. Lafi, B. Sheppard, S. Orloff, G. Vaccaro, C. Lopez, K. G. Billingsley Oregon Health and Sciences University, Portland, OR op-ii.03. prospeCtive analYsis oF taCe as priMarY tHerapY in HCC ManaGeMent K. Collins, N. Saad, N. Vachharajani, K. Fowler, K. Korenblat, M. Doyle, W. Chapman Washington University School Of Medicine, St. Louis, MO op-ii.04. MiniMallY invasive MiCroWave ablation oF earlY staGe HepatoCellular CarCinoMa F. Alemi, K. Specht, K. Kowdley, A. Siddique, R. Crane, E. Hauptmann, M. Fotoohi, A. Alseidi, T. R. Biehl, S. Helton, F. G. Rocha Virginia Mason Medical Center, Seattle, WA op-ii.05. liver reseCtion WitH HepatiC vein reConstruCtion is a viable option in seleCted patients R. Smoot, J. Conneely, P. Serrano, D. Cavallucci, I. McGilvray University Of Toronto, Toronto, Ontario, Canada op-ii.06. novel radioFreQuenCY ablation sYsteM inCorporatinG MaGnetiC traCKinG in porCine Model M. Brown, M. A. Cassera, W. Johnston, C. W. Hammill Hepatobiliary And Pancreatic Surgery Program, Portland, OR op-ii.07. patterns oF reCurrenCe FolloWinG MarGin- positive reseCtion oF ColoreCtal liver Metastases C. W. Michalski, J. Wagner, B. Sheppard, S. L. Orloff, G. Vaccaro, C. Lopez, K. G. Billingsley Oregon Health And Science University, Portland, OR op-ii.08. tHe slipperY slope oF Cross ClaMpinG vs open surGerY: is tHe CHoiCe obvious? T. Dominioni, J. Viganò, L. Cobianchi, A. Peloso, J. Ferrario, A. D’addiego, I. Benzoni, P. Dionigi, M. Maestri Fondazione IRCCS Policlinico San Matteo, Pavia, Italy




op-ii.09. treatMent response oF HepatoCellular CarCinoMa bY etioloGY oF liver disease R. M. Seshadri, D. J. Niemeyer, J. Lee, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo, D. A. Iannitti Carolinas Medical Center, Charlotte, NC op-ii.10. reduCuCtion oF CoMpliCations: tHe proGression oF laparosCopiC liver reseCtion A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil, J. Buell Tulane Transplant Institute, New Orleans, LA

Group: liver iv op-ii.11. an enHanCed reCoverY in liver surGerY (erils) patHWaY For MiniMallY invasive and open HepatiC reseCtion deMonstrates earlier return to norMal FunCtion and intended onColoGiC tHerapies T. A. Aloia, A. Cooper, C. Conrad, J. Vauthey, V. Gottumukkala University of Texas MD Anderson Cancer Center, Houston, TX op-ii.12. Cost eFFeCtive analYsis oF altrus versus Cusa For liver reseCtions G. R. Beck, K. P. Croome, R. Hernandez-Alejandro University Of Western Ontario, London Health Science Centre, London, Ontario, Canada op-ii.13. iMMunoHistoCHeMiCal tuMor MarKers in tHe diaGnostiCs oF FoCal liver lesions J. Vilmanis, I. Strumfa, A. Ozolins, R. Stucka, J. Gardovskis, . Pauls Stradins Clinical University Hospital, Riga, Latvia op-ii.14. laparosCopiC ManaGeMent oF CYstiC disease oF tHe liver A. Hauch, S. Lee, E. Kane, E. Kandil, J. Buell Tulane Transplant Institute, New Orleans, LA




op-ii.16. WHen surGiCal sHuntinG is tHe best or onlY option: a Case series L. M. Louwers, V. Raofi, S. Cohn, A. Koffron Henry Ford Health System, Detroit, MI; Beaumont Health System/Oakland University School Of Medicine, Royal Oak, MI op-ii.18. epideMioloGY oF MetastatiC Colon CanCer aMonG saudis F. Al-alem, E. Simoneau, T. A. Traiki, N. Al-malki, K. Alkhayal, A. Zubaidi, O. Obaid, M. Hassanain King Saud University, Saudi Arabia, Riyadh; McGill University Health Center, Montreal, Quebec, Canada op-ii.19. MaliGnant MasQuerade oF pet-Ct avid HepatiC adenoMa F. Alemi, T. Mohammed, P. Sicuro, K. Kowdley, A. Siddique, A. Alseidi, T. Biehl, S. Helton, F. Rocha Virginia Mason Medical Center, Seattle, WA op-ii.20. Meld prediCts MortalitY in ConservativelY ManaGed CirrHotiCs WitH pneuMatosis F. Karipineni, J. Pang, A. Parsikia, J. Ortiz Albert Einstein Medical Center, Philadelphia, PA Group: panCreas iii op-ii.23. panCreatiCoduodeneCtoMY in tHe oldest oF old: results beYond operative MortalitY R. C. Langan, P. R. Bucciarelli, W. Chapman, K. Oza, C. Fehring, P. G. Jackson, T. M. Fishbein, R. Jha, N. Haddad, F. Al-Kawas, J. Carroll, J. Hanna, A. Parker, W. B. Al-Refaie, L. B. Johnson Georgetown University Hospital, Washington, DC op-ii.24. analYsis oF patenCY rates in portoMesenteriC venous reConstruCtion durinG panCreatiC reseCtion M. Brown Providence Portland Medical Center, Portland, OR




op-ii.25. tiMe to adJuvant tHerapY For laparosCopiC panCreatiC reseCtion T. Sachs, M. Cooper, T. Pawlik, M. Choti, L. Zheng, J. Herman, D. Laheru, J. Cameron, C. Wolfgang, M. Makary, M. Weiss Johns Hopkins Medical Institution, Baltimore, MD op-ii.26. iMpaCt oF MultidisCiplinarY Hepato-panCreato-biliarY Case ConFerenCe on tHe ManaGeMent oF panCreatiC CanCer K. Mayer, Y. Kuo, J. M. Davis, A. Adams, O. Cabasso, J. J. Vernick, E. J. Hagopian Jersey Shore University Medical Center, Neptune, NJ; Robert Wood Johnson Medical School, New Brunswick, NJ op-ii.28. is tHere a “JulY eFFeCt” For Hpb Cases? S. Patel, S. Cheek , T. Winston , H. Osman , D. Jeyarajah Methodist Dallas, Dallas, TX op-ii.29. tHe use and utilitY oF abdoMinal Ct sCans in tHe iMMediate postoperative period FolloWinG panCreatiC reseCtions S. Zenoni, P. Veldhuis , S. Eubanks, S. G. De La Fuente, P. Arnoletti Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL op-ii.30. Groove panCreatitis: a rare MiMiCKer oF panCreatiC CanCer WHiCH Can be treated WitH panCreatiCoduodeneCtoMY S. Rabi, J. Cameron, M. Makary, K. Hirose, N. Rezaee, T. Pawlik, R. Hruban, C. Wolfgang, . , M. Weiss The Johns Hopkins Hospital, Baltimore, MD

Group: panCreas iv op-ii.31. survival beneFit oF adJuvant tHerapY For borderline reseCtable (blr) panCreatiC CanCer (pC) treated WitH neoadJuvant tHerapY K. Duelge, A. N. Krepline, A. Mahmoud, B. George, P. S. Ritch, B. A. Erickson, E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gamblin, K. K. Christians, D. B. Evans, S. Tsai Medical College of Wisconsin, Milwaukee, WI




op-ii.33. perioperative MorbiditY and MortalitY aFter panCreateCtoMY: a sYsteMatiC revieW oF prediCtion sCores, Models and noMoGraMs J. Aubin, R. Lapointe, F. Vandenbroucke-Menu, G. Martel The Ottawa Hospital, University Of Ottawa, Ottawa, Ontario, Canada; Hôpital Saint-Luc, CHUM, Montreal, Quebec, Canada op-ii.34. tHe iMpaCt oF aberrant anatoMY oF tHe HepatiC arterY on reseCtion MarGin status in panCreatiCoduodeneCtoMY P. Casey, R. De Souza, S. Lapsia, Z. Ali, K. Elhadd, A. Kausar, D. Chang, A. Krige, J. Thomas, D. Subar Royal Blackburn Hospital, Lancashire, United Kingdom op-ii.35. diFFerenCes in outCoMes in panCreatiCoduodeneCtoMY (pd) in tHe Modern era: does a MaliGnant diaGnosis MaKe a diFFerenCe? S. Cheek, S. Patel, H. Osman, D. Jeyarajah Methodist Dallas Medical Center, Dallas, TX op-ii.36. tHe beneFits oF laparosCopiC panCreateCtoMY: it does MaKe a diFFerenCe S. Cheek , S. Patel, H. Osman , D. Jeyarajah Methodist Dallas Medical Center, Dallas, TX op-ii.37. lonG-terM survival aFter reseCtion oF panCreatiC CanCer: siGniFiCanCe oF earlY deteCtion and HistoloGiCallY Curative reseCtion T. Yamamoto, H. Kinoshita, Y. Sakamoto, K. Okada, K. Inoguchi, S. Yao, S. Kaihara, R. Hosotani, S. Yagi Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan op-ii.38. soCioeConoMiC status and surGiCal outCoMes aFter total panCreateCtoMY H. Schmidt, E. M. Kilbane, A. P. Turner, M. G. House, N. J. Zyromski, A. Nakeeb, C. M. Schmidt, E. P. Ceppa Indiana University School Of Medicine, Indianapolis, IN




op-ii.39. outCoMes in open versus laparosCopiC distal panCreateCtoMY R. Pieretti- Vanmarcke, J. Wargo, C. Fernandez-Del Castillo, H. Zheng, A. Merrill, S. Thayer, K. Lillemoe, C. R. Ferrone Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA op-ii.40. outCoMe aFter revision oF tHe panCreatiCoJeJunostoMY: a sinGle institution eXperienCe A. I. Gagnon, R. Birkett, T. Schnelldorfer Lahey Clinic, Burlington, MA Group: triCKs oF trade op-ii.43. 10 steps to salvation - ControllinG an ivC bleed durinG MaJor HepateCtoMY J. B. Conneely, S. Jayaraman University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre, Toronto, Ontario, Canada op-ii.44. saFe and easY prinGle For laparosCopiC liver reseCtion M. M. Dua, D. J. Worhunsky, K. J. Hwa, B. Siu, G. A. Poultsides, J. A. Norton, B. C. Visser Stanford University School Of Medicine, Stanford, CA; VA Palo Alto Health Care System, Palo Alto, CA op-ii.45. triCKs oF tHe trade: operative ManaGeMent oF portal annular panCreas in patients underGoinG panCreatiCoduodeneCtoMY A. V. Maker, V. K. Maker University Of Illinois At Chicago, Chicago, IL




op-ii.46. tranCYstiC biliarY desCoMpression WitH internal-eXternal biliarY drainaGe plaCed laparosCopiCallY aFter bile duCt eXploration. preliMinarY report oF an innovative teCHniQue. G. E. Pfaffen, P. Barros Schelotto, P. Romero , G. E. Gondolesi Fundacion Favaloro, Buenos Aires, Argentina op-ii.48. intraHepatiC CHolanGioJeJunostoMY For tHe treatMent oF CoMpleX biliarY stenosis aFter pediatriC livinG-donor liver transplantation R. Sanchez Clariá, F. A. Alvarez, N. Resio, E. De Santibañes, M. Ciardullo Hospital Italiano De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina op-ii.49. ultrasound-Guided intraoperative transduodenal panCreatiC Head biopsY – a saFe and eFFeCtive proCedure to eXClude MaliGnanCY For obstruCtive JaundiCe patients: teCHniCal note N. Ikoma, T. Karahashi, Y. Hosoda Saitama Social Insurance Hospital, Kitaurawa, Saitama, Japan op-ii.50. ConCept oF tHe MesopanCreas: CoininG a neW surGiCal anatoMiCal spaCe S. Patel, S. Cheek , H. Osman, D. Jeyarajah Methodist Dallas, Dallas, TX Group: biliarY op-ii.51. FaCtors prediCtive oF CHoledoCHolitHiasis. optiMizinG ManaGeMent strateGies C. Rengifo, D. Chang, R. Watson, A. Kausar, D. Subar Royal Blackburn Hospital, Lancashire, United Kingdom op-ii.53. CoMpliCations aFter surGiCal repair oF bile duCt inJurY D. Zamora-Valdés, M. Vilatoba, A. G. Contreras, I. Dominguez-Rosado, A. L. Carrete, M. Gonzalez, C. Kaufmann, E. M. Saucedo, S. Mier, M. A. Mercado Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, México D.F., México





op-ii.54. CoMpliCations oF perCutaneous CHoleCYstostoMY tube (pC) in tHe treatMent oF aCute CHoleCYstitis (aC) A. D. Guerron, A. Abdel Azim, M. Moorman, G. McLennan, M. Loor Cleveland Clinic Foundation, Cleveland, OH op-ii.55. prediCtinG (avoidinG) inCidental Gallbladder CanCer K. Patel, A. Sautter, T. Buddensick, B. Wu, H. Ferdosi, D. Narducci, M. Siddique, L. Setiawan, H. Shaukat, G. Sulkowski, S. O. Farooqui, G. C. Kowdley, S. C. Cunningham Saint Agnes Hospital And Cancer Institute, Catonsville, MD op-ii.56. sHort terM pHYsioloGiCal eFFeCts oF a HepatopanCreatiCobiliarY reservoir A. Yusuf, B. Asiyanbola University Of Maryland, Easton Memorial, Easton, MD; Johns Hopkins Center For Talented Youth, Baltimore, MD op-ii.57. neuroendoCrine neoplasMs oF tHe eXtraHepatiC bile duCt: report oF siX Cases N. Hong, H. Kim Asan Medical Center, University Of Ulsan College Of Medicine, Seoul, Songpa-Gu, South Korea op-ii.58. inCidental Gallbladder CanCer on CHoleCYsteCtoMY: is tHere More tHan Meets tHe eYe? S. Patel, S. Cheek , T. Winston , H. Osman, D. Jeyarajah Methodist Dallas, Dallas, TX op-ii.59. novel strateGY For suspeCted pt2 Gallbladder CarCinoMa bY laparosCopiC approaCH O. Itano, G. Oshima, M. Shinoda, M. Kitago, Y. Abe, T. Hibi, H. Yagi, S. Aiko, Y. Kitagawa Keio University School Of Medicine, Tokyo, Japan; Eiju General Hospital, Tokyo, Japan op-ii.60. CHoleCYsteCtoMY in CirrHotiC patients. WHen to operate? L. SAROTTO, J. PALEARI, H. TODESCHINI, P. FERRAINA, . Instituto Quirurgico Del Callao, Capital Federal, Buenos Aires, Argentina; Universidad De Buenos Aires, University Of Medicine, Capital Federal, Buenos Aires, Argentina




7:45pm - 9:30pm

Parallel Educational Dinner Symposia: PNET Update Ocean Tower 1 A-C Moderator: Matthew H. Katz

Surgery for Non-Functional pNET: Open and Laparoscopic Techniques Clifford S. Cho, MD

Hepatectomy, Transplantation and Non-invasive Liver Directed Therapies for Metastatic Neuroendocrine Tumors Mark Bloomston, MD

Targeted and Systemic Strategies for Advanced Neuroendocrine Tumors Matthew Kulke, MD

Management of Hereditary pNET: The Surgeon’s Role Jeffrey E. Lee, MD 7:45pm - 9:30pm

Parallel Educational Dinner Symposia: Thermal Ablation: An Update of Techniques and Outcomes Ocean Tower II A-B Moderator: David Sindram, MD

Introduction David Sindram, MD

Ice and Alcohol, A Good Start Ramanathan Seshadri, MD

RFA True and Tested, But Still? Paul D. Hansen, MD

Actual Data Behind MWA Ryan Groelsch, MD 8:00pm

Oral Poster Presentations II – Teardown Mona Lisa



sundaY, FEBruAry 23, 2014

7:00am - 8:30am Continental breakfast Ocean Tower 1 & 2 Foyer 7:30am - 1:00pm aHpba registration open Ocean Tower 1 & 2 Foyer 7:30am - 11:00am speaker ready room open San Marino 7:30am - 8:30am

Parallel - Competitive Videos A: Liver Support for this session provided by Ethicon, Inc. Ocean Tower 1 A-C Moderators: Thomas A. Aloia, MD; Felipe Jose Fernandez Coimbra, MD Cv-a.01. totallY laparosCopiC riGHt HepateCtoMY bY Caudate HepatotoMY teCHniQue C. U. Corvera, V. Kuo University Of California San Francisco, San Francisco, CA Cv-a.03. laparosCopiC riGHt posterior seGMent liver reseCtion M. M. Augustine, T. P. Kingham Memorial Sloan Kettering Cancer Center, New York, NY Cv-a.04. robotiC-assisted riGHt HepateCtoMY E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares, R. Caruso, R. Ceron, J. Plaza Sanchinarro University Hospital, Madrid, Spain Cv-a.05. laparosCopiC leFt HepateCtoMY CoMbininG Cusa and HarMoniC sCalpel disseCtion J. B. Conneely, R. Smoot, S. Cleary Toronto General Hospital, Toronto, Ontario, Canada




7:30am - 8:30am

Parallel - Competitive Videos B: Pancreas / Biliary Ocean Tower II A- B Moderators: Nicholas J. Zyromski, MD; Juan Pekolj, MD Cv-b.01. CoMpletion radiCal CHoleCYsteCtoMY and portal lYMpHadeneCtoMY: MiniMallY invasive teCHniQues For ManaGeMent oF inCidental Gallbladder CarCinoMa S. Lee, M. I. D’Angelica, W. R. Jarnagin, T. P. Kingham Memorial Sloan-Kettering Cancer Center, New York , NY Cv-b.02. surGiCal aspeCts oF tHe MesenteriCoportal venous reseCtion in Hepato-bilio-panCreatiC surGerY E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares, R. Caruso, R. Ceron, A. Cubillo, J. Plaza Sanchinarro University Hospital, Madrid, Spain Cv-b.03. panCreatiC neuroendoCrine tuMor WitH CeliaC aXis involveMent V. M. Cano Busnelli, F. A. Alvarez, J. Pekolj HPB Surgery Section And Liver Transplant Unit. Hospital Italiano De Buenos Aires, Buenos Aires, Argentina Cv-b.04. laparosCopiC CoMMon bile duCt eXploration For iMpaCted CHoledoCHolitHiasis S. Jayaraman University Of Toronto, Toronto, Ontario, Canada Cv-b.05. laparosCopiC partial sleeve duodeneCtoMY (psd) For duodenal adenoMa J. A. Stauffer, H. J. Asbun Mayo Clinic, Jacksonville, FL




8:30am - 9:30am

Surgical Volunteerism Update: The 3rd AHPBA Symposium on Humanitarian Medical Outreach Teams: Supporting Local Chapters with Capacity Building Ocean Tower 1 A-C Moderators: Sean P. Cleary, MD & Nestor Gomez, MD

International Relations Committee Travel Awards W. Scott Helton, MD, William C. Chapman, MD & Sean P. Cleary, MD

AHPBA Outreaach Team in Ecuador David M. Nagorney, MD

AHPBA Outreach Team in Costa Rica William R. Jarnagin, MD

AHPBA Outreach Team in Nicaragua Quyen D. Chu, MD, MBA

AHPBA Outreach Team in Honduras Wesley P. Francis, MD 9:30am - 10:30am

Parallel Debates: Transplantation for Neuroendocrine Tumors Ocean Tower 1 A-C Moderator: Christopher D. Anderson, MD

Pro: Nipun Merchant, MD Con: Christopher J. Sonnenday, MD 9:30am - 10:30am

Parallel Debates: Should We Limit the Number of HPB Fellowships? Ocean Tower II A-B Moderator: D. Rohan Jeyarajah, MD

Pro: Elijah Dixon, MD Con: Paul D. Greig, MD




10:30am - 12:30pm

Parallel Mini Oral Abstracts A: Liver / Transplant Ocean Tower 1 A-C Moderators: Henry B. Randall, MD; Niraj Gusani, MD, MS Mo-a.01. overall survival bY pattern oF reCurrenCe FolloWinG Curative intent surGerY For ColoreCtal liver Metastasis A. N. Kulaylat, J. R. Schubart, A. L. Stokes, E. T. Kimchi, K. F. Staveley-O’Carroll, N. J. Bhayani, J. T. Kaifi, N. J. Gusani Penn State Hershey Cancer Institute, Hershey, PA Mo-a.03. alterations in Hippo siGnalinG patHWaY durinG liver reGeneration J. Grijalva, M. Huizenga, F. Camargo, G. Sadri-Vakili, K. Vakili Boston Children’s Hospital, Boston, MA; Massachusetts General Hospital, Charlestown, MA Mo-a.04. validation oF tHe seleCtion Criteria For saFe HepateCtoMY For HepatoCellular CarCinoMa: analYsis oF 312 ConseCutive HepateCtoMies. M. Donadon, F. Procopio, M. Cimino, G. Costa, D. Del Fabbro, A. Palmisano, A. Gatti, G. Torzilli Humanitas Clinical And Research Center, Rozzano, Milan, Italy Mo-a.05. readMission aFter HepatiC reseCtion at a QuaternarY aCadeMiC Center A. Ejaz, G. Spolverato, D. Lucas, M. Weiss, C. Wolfgang, K. Hirose, M. Choti, T. M. Pawlik Johns Hopkins Hopsital, Baltimore, MD Mo-a.06. QualitY oF liFe aFter reseCtion oF intra- and eXtra-HepatiC Metastases FroM ColoreCtal adenoCarCinoMa in a Multi-Center prospeCtive pHase ii trial P. E. Serrano, N. G. Coburn, K. S. Devitt, C. Moulton, S. P. Cleary, C. Law, P. D. Greig, S. Gallinger, A. C. Wei University of Toronto, Toronto, Ontario, Canada




Mo-a.07. intraoperative ultrasound and surGiCal strateGY in HepatiC reseCtion: WHat diFFerenCe does it MaKe? R. Jrearz, R. S. Hart, S. Jayaraman University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre, Toronto, ON Mo-a.08. reliabilitY, saFetY and onColoGiCal suitabilitY oF intraoperative ultrasound Criteria For HepatiC veins sparinG onCe in ContaCt WitH ColoreCtal liver Metastases at tHe Caval ConFluenCe: validation on an intention to treat analYses F. Procopio, M. Donadon, M. Cimino, D. Del Fabbro, G. Costa, A. Gatti, A. Palmisano, G. Torzilli University Of Milan-School Of Medicine, Humanitas Clinical And Research Center, Rozzano, Milan, Italy Mo-a.09. preoperative prediCtive Model oF survival aFter reseCtion For intraHepatiC CHolanGioCarCinoMa (iHCC) A. Schneck, D. Subar, R. Memeo, F. Vittore, P. Compagnon, A. Laurent, D. Azoulay APHP Henri Mondor Hospital, Créteil, Val De Marne, France; Royal Blackburn Hospital, Lancashire, United Kingdom Mo-a.10. outCoMes oF unreseCtable solitarY HepatoCellular CarCinoMas sized 5 to 8 CM treated bY radioFreQuenCY ablation versus transarterial CHeMoeMbolization W. Dai , T. Cheung, R. Poon The University Of Hong Kong, Hong Kong, China Mo-a.11. tHe assoCiation oF HYpopHospHateMia WitH post-HepatetCtoMY liver Failure and reCoverY J. Hallet, F. Zih, J. Wong, E. Cheng, S. Hanna, P. Karanicolas, N. Coburn, C. Law University Of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada




Mo-a.12. validation oF our poliCY oF lonG-terM drains MaintenanCe aFter HepatiC reseCtion: results oF a prospeCtive CoHort analYsis. M. Donadon, G. Costa, F. Procopio, M. Cimino, D. Del Fabbro, A. Palmisano, A. Gatti, G. Torzilli University Of Milan-School Of Medicine, Humanitas Clinical And Research Center, Rozzano, Milan, Italy Mo-a.13. liver CanCer in teXas: environMental risK FaCtors ContributinG to HiGHer inCidenCe rate D. Zorzi, G. Curcuru’, C. Rhoads, V. Gazis, C. Rastellini, L. Cicalese UTMB, Galveston, TX; University Of Palermo, Palermo, PA Mo-a.14. (siGMa-2/sMaC) is a stronG enHanCer oF GeMCitabine sensitivitY in panCreatiC adenoCarCinoMa Y. Hashim, D. Spitzer, S. Vangveravong, P. Goedegebuure, M. Hornick, R. Mach, W. Hawkins Washington University School Of Medicine, St Louis, MO; University Of Pennsylvania, Philadelphia, PA Mo-a.16. HiGH utilization oF liver transplantation For HepatoCellular CarCinoMa: is it ConCerninG? A. E. Alsina, K. Vu, J. Arrobas, E. Franco, N. Kemmer, G. W. Neff, A. Valencia, S. Houston Tampa General Hospital, Tampa, FL; University Of South Florida, Morsani College Of Medicine, Tampa, FL Mo-a.17. reoperation For bleedinG FolloWinG liver transplantation D. A. DuBay, D. T. Redden, M. A. Thompson, L. Glueckert, A. B. Smith, J. H. Crawford, K. A. Jones, S. H. Gray, J. White, D. E. Eckhoff University Of Alabama At Birmingham, Birmingham, AL




Mo-a.18. tHe iMpaCt oF pre-transplant Hospitalization on post-operative lenGtH oF staY and Cost oF liver transplantation S. J. Knechtle, L. I. Brummett, C. Devroy, R. Subramanian, A. B. Adams, J. Magliocca, J. Spivey Emory University School Of Medicine, Atlanta, GA Mo-a.19. survival outCoMes in liver transplant reCipients WitH Meld oF 40 and HiGHer –a deCade lonG eXperienCe H. J. Panchal, J. Patterson, J. Durinka, J. Ortiz Mount Sinai School Of Medicine, NY, NYLincoln Medical And Mental Health Center, NY, NYAlbert Einstein Healthcare Network, Philadelphia, PA Mo-a.20. tHe use oF venous JuMp GraFts in panCreas transplantation is not assoCiated WitH inCreased GraFt Failure or MortalitY E. Siskind, M. Akerman, S. Ashburn, E. Molmenti, A. Basu, J. Ortiz North Shore Long Island Jewish Health System, Manhasset, NY; Albert Einstein Medical Center, Philadelphia, PA 10:30am - 12:30pm

Parallel Mini Oral Abstracts B: Pancreas / Biliary Ocean Tower II A-B Moderators: John B. Martinie, MD; Hernan A. de la Fuente, MD Mo-b.01. is CHroMoGranin a proGnostiC For reseCted panCreatiC neuroendoCrine tuMors? M. A. Shanahan, C. S. Cho, P. A. Rudnitzky, G. Leverson, E. R. Winslow, S. M. Weber University Of Wisconsin School Of Medicine & Public Health, Madison, WI Mo-b.02. deteCtion oF soMatiC Mutations in diaGnostiC Fine needle aspirates oF panCreatiC CanCer WitH neXt-Generation seQuenCinG V. Valero, T. J. Saunders, R. H. Hruban, J. L. Cameron, J. M. Herman, C. A. Iacobuzio-Donahue, C. L. Wolfgang The Johns Hopkins University School Of Medicine, Baltimore, MD




Mo-b.04. CoMparison oF robot versus open panCreatiCoduodeneCtoMY B. A. Boone, S. Downs-Canner, J. Steve, M. S. Zenati, M. E. Hogg, A. J. Moser, D. L. Bartlett, H. A. Choudry, H. J. Zeh, A. H. Zureikat University Of Pittsburgh, Pittsburgh, PA; Beth Israel Deaconess Medical Center, Boston, MA Mo-b.05. General surGerY resident partiCipation in CoMpleX panCreatiC proCedures Y. Tilahun, P. Veldhuis, S. Eubanks, P. Arnoletti, S. G. De La Fuente Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL Mo-b.06. diaGnostiC laparosCopY sHould be perForMed beFore deFinitive reseCtion For panCreatiC CanCer: a FinanCial arGuMent T. T. Jayakrishnan, H. Nadeem, R. T. Groeschl, B. George, J. P. Thomas, P. S. Ritch, K. K. Christians, S. Tsai, D. B. Evans , S. G. Pappas, T. C. Gamblin, K. K. Turaga Medical College Of Wisconsin, Milwaukee, WI; Loyola University Medical Center, Maywood, IL Mo-b.07. tHe eFFeCt oF MarGin status on survival FolloWinG panCreatiCoduodeneCtoMY D. J. Niemeyer, R. M. Seshadri, R. Z. Swan, D. Sindram, R. Nazemzadeh, J. B. Martinie, D. A. Iannitti Carolinas Medical Center, Charlotte, NC Mo-b.08. neoadJuvant radiation is eQuivalent to adJuvant radiation FolloWinG panCreatiCoduodeneCtoMY For staGe ii and iii adenoCarCinoMa D. J. Niemeyer, R. M. Seshadri, R. Z. Swan, D. Sindram, A. J. Crimaldi, J. B. Martinie, D. A. Iannitti Carolinas Medical Center, Charlotte, NC




Mo-b.09. risK FaCtors For panCreatiC Fistula aFter robotiC panCreatiCoduodeneCtoMY P. M. Polanco, M. E. Hogg, M. Shakir, M. S. Zenati, M. Choudry, B. A. Boone, D. L. Bartlett, H. Zeh, A. H. Zureikat University Of Pittsburgh Medical Center, Pittsburgh, PA Mo-b.10. in-Hospital MortalitY FolloWinG panCreatiCoduodeneCtoMY. J. He, M. Weiss, J. Cameron, N. Ahuja, K. Hirose, T. Pawlik, C. Wolfgang, . Johns Hopkins Medical Institutions, Baltimore, MD Mo-b.11. Hospital readMission aFter panCreatiCoduodeneCtoMY in a HiGH voluMe Center J. Rose, F. B. Rocha, A. Alseidi, T. B. Biehl, S. Helton Virginia Mason Medical Center, Seattle, WA Mo-b.12. QuantitY and QualitY: a HiGH voluMe panCreatiC Center’s adHerenCe to HiGHlY validated QualitY Measures oF panCreatiC CanCer Care M. Ongchin, J. Steve, D. Bartlett, M. Choudry, K. Lee, W. Marsh, A. Tsung, A. Zureikat, H. Zeh, M. Hogg University Of Pittsburgh, Pittsburgh, PA Mo-b.13. tuMor staGe at presentation and aCCess to surGerY is not inFluenCed bY raCe in panCreatiC CanCer patients Y. Tilahum , X. Zhu , S. Litherland, P. Veldhuis , D. A. Decker, S. Eubanks, A. Simmonds, P. Arnoletti, S. G. De La Fuente Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL Mo-b.15. panCreateCtoMY in patients on CHroniC dialYsis: is it too risKY? S. W. Cho, J. S. Cardinal West Virginia University Hospitals, Morgantown, WV




Mo-b.16. adJuvant CHeMotHerapY provides better overall survival aFter radiCal reseCtion For panCreatiC adenoCarCinoMa. S. Hurton, F. MacDonald, S. Ayloo, M. Molinari Dalhousie University, Halifax, Nova Scotia, Canada Mo-b.17. learninG Curve For robotiC distal panCreateCtoMY M. Shakir, M. Khreiss, P. M. Polanco, B. A. Boone, M. Zenati , M. Hogg, M. H. Choudry, D. L. Bartlett, H. Zeh, A. H. Zureikat University Of Pittsburgh Medical Center, Pittsburgh, PA Mo-b.18. obesitY is an independent prediCtor oF bile duCt inJuries in patients underGoinG CHoleCYsteCtoMY H. Aziz, A. Amini, V. Pandit, T. Jie, E. Ong University Of Arizona, Tucson, AZ Mo-b.19. a sYsteMatiC revieW and Meta-analYses oF HepatiC arterY based tHerapies For unreseCtable intraHepatiC CHolanGioCarCinoMa L. Boehm, T. Thayyil Jayakrishnan, J. Miura, K. K. Turaga, F. M. Johnston, S. Tsai, T. C. Gamblin Medical College Of Wisconsin, Milwaukee, WI Mo-b.20. Hospital readMissions rates FolloWinG open and laparosCopiC CHoleCYsteCtoMY L. Watkins, P. Veldhuis , S. Eubanks, P. Arnoletti, S. G. De La Fuente Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL 12:30pm - 1:00pm Closing address and raffle Incoming President: Elijah Dixon, MD Ocean Tower 1 A-C



SPECiAL THANKS TO Our

BrONZE SPONSOr



SPEAKErS ANd FACuLTy

Reid B. Adams UVA Health System Rodolfo Alejandro Diabetes Research Institute, University of Miami Noaman S. Ali Cleveland Clinic Thomas A. Aloia MD Anderson Cancer Center Christopher D. Anderson University Of Mississippi Medical Center Horacio j. Asbun Mayo Clinic Jacksonville Chad G. Ball University Of Calgary Eren Berber Cleveland Clinic Foundation Dario Eduardo Berkowski Clinicas Hospital, University of Buenos Aires Mark Bloomston Ohio State University Daniel Brown Vanderbilt University L. Michael Brunt Washington University Institute Eugene P. Ceppa Indiana University School of Medicine

William C. Chapman Washington University School of Medicine Clifford S. Cho University Of Wisconsin School of Medicine And Public Health Quyen D. Chu Louisiana State University Health Sciences Center - Shreveport Bryan M. Clary Duke University Medical Center Pierre-Alain Clavien University Hospital Zurich Sean P. Cleary Toronto General Hospital Amanda B. Cooper MD Anderson Cancer Center Sebastian G. de la Fuente Florida Hospital Orlando - UCF Elijah Dixon University Of Calgary Maria B. Majella Doyle Washington University School of Medicine Ryan C. Fields Washington University School of Medicine Mary E. Fischer Memorial Sloan Kettering Cancer Center



SPEAKErS ANd FACuLTy continued

jason B. Fleming University of Texas MD Anderson Cancer Center katherine Fowler Washington University St. Louis Wesley P. Francis Princess Margaret Hospital Steven Gallinger University Health Network O. james Garden Royal Infirmary of Edinburgh David A. Geller University of Pittsburgh Octavio Gil Sanatorio Allende Chris Giordano University of Florida - Gainesville Nestor Arturo Gomez Universidad De Guayaquil Gabriel Eduardo Gondolesi Fundacion Favaloro Vijaya Gottumukkala MD Anderson Cancer Center Paul D. Greig University Of Toronto Ryan Groeschl Medical College Of Wisconsin

Ellen j. Hagopian Jersey Shore University Medical Center Chet Hammill The Oregon Clinic Erin M. Hanna Baker Carolinas Medical Center Paul D. Hansen Providence Portland Medical Center W. Scott Helton Virginia Mason Medical Center Alan W. Hemming University Of California, San Diego Mary Beth Henry University of Wisconsin Hospital Paulo Herman University Of Sao Paulo Medical School Pamela j. Hodul Moffitt Cancer Center Melissa E. Hogg University of Pittsburgh Medical Center William R. Hutson University of Maryland David A. Iannitti Carolinas Medical Center Oscar Cesar Imventarza Hospital Argerich/Hospital Garrahan




William R. jarnagin Memorial Sloan Kettering Cancer Center Nicolas P. jarufe Cassis Pontificia Universidad Catolica De Chile D. Rohan jeyarajah Methodist Hospital Dallas Ivan kangrga Washington University St. Louis Matthew H. katz MD Anderson Cancer Center Matthew kulke Dana Farber Cancer Institute jeffrey E. Lee MD Anderson Cancer Center David C. Linehan Washington University School of Medicine kevin Lowe Akron General Medical Center Lindsey Manos The Johns Hopkins Hospital john Mansour University of Texas Southwestern Medical Center Robert C. G. Martin, II University of Louisville john B. Martinie Carolinas Healthcare System

Erin Maynard University of Kentucky Erin McIntyre University of Colorado Hospital Miguel Angel Mercado Instituto Nacional de la Nutricion Nipun B. Merchant Vanderbilt University Michele Molinari Dalhousie University katherine Morgan Medical University of South Carolina A. james Moser Beth Israel Deaconess Medical Centre David M. Nagorney Mayo Clinic College of Medicine Nathan Ogilvie Wake Forest Baptist Health Susan L. Orloff Oregon Health & Science University Timothy M. Pawlik Johns Hopkins Srinevas k. Reddy University of Maryland School of Medicine kaye M. Reid Lombardo Mayo Clinic Richard Reznick Queen’s College, Canada




Flavio G. Rocha Virginia Mason Medical Center Lauren Rorabaugh Carolinas Healthcare System Rodrigo Sanchez Claria Hospital Italiano Buenos Aires C. Max Schmidt Indiana University School Of Medicine Roderich E. Schwarz IU Health Goshen Center for Cancer Care Ramanathan Seshadri Carolinas Medical Center Shimul A. Shah University of Cincinnati Mohd Raashid Ali Sheikh University of Illinois Chicago Margo C. Shoup Cadence Health David Sindram Carolinas Medical Center Allan E. Siperstein Cleveland Clinic Luc Soler IRCAD, France Christopher j. Sonnenday University of Michigan Steven M. Strasberg Washington University St. Louis

Mark S. Talamonti NorthShore University HealthSystem Allan Tsung University Of Pittsburgh Medical Center jean-Nicolas Vauthey MD Anderson Cancer Center Charles M. Vollmer University Of Pennsylvania School of Medicine Susanne G. Warner University of Michigan Andrew L. Warshaw Massachusetts General Hospital Sharon M. Weber University of Wisconsin Hospital Alice C. Wei University Health Network, University Of Toronto Rebekah White Duke University Christopher L. Wolfgang Johns Hopkins University School Of Medicine Gazi B. zibari Willis Knighton Health System Nicholas j. zyromski Indiana University



The power to offer new hope to your patients with liver metastases

In the US, SIR-Spheres microspheres are FDA approved for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). SIR-Spheres microspheres are approved for use in Australia, the European Union (CE Mark), New Zealand, Switzerland, Turkey and several other countries in Asia (e.g. India, Korea, Singapore and Hong Kong) for the treatment of unresectable liver tumors. SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.

Sirtex Medical Inc., 300 Unicorn Park Drive, Woburn, MA 01801 888.474.7839 www.sirtex.com 771-U-1013

Download our iPad App for comprehensive information about Selective Internal Radiation Therapy (SIRT). Visit www.sirspheresmicrospheres.com

You have the target. We have the weapon.











































FLOOrPLANS &

ExHiBiT iNFOrMATiON



HOTEL FLOOrPLANS

HIBISCUS

BAYSHORE

STAR

PALM

LIL GORCE

KEY BISCAYNE

A

KEY BISCAYNE

B

FISHER

A

FISHER B

BELLE

SAN MARCO

SAN MARINO

EXECUTIVE

BOA

RDRO

OM

RIVO

ALTO

PALLADIIUM

BUSINESS

CENTERGROUP OFFICE

Lower Lobby Level

Conference Level

Mezzanine Level



POMPEII BALLROOM

PROMENADE ROOM

MONA LISA FOYER

MONA LISA

RECEPTION

LOBBY

RESTAURANT

PROMENADE

FOYER

Lobby Level

A B

OCEAN

BALLROOM

IIA

OCEAN BALLROOM

IIB

OCEAN BALLROOM

IIC

LAPIDUS

WATSON

OCEAN BALLROOM

IA

OCEAN BALLROOM

IB

OCEAN BALLROOM

IC

Penthouse FloorOcean Tower

SUNNY ISLES BAL

HARBOUR

WATER

VEIW

TERRACE



ExHiBiT HALL diAgrAM

SHOW ENTRANCE

VIDEO PRESENTATIONS

BAR

visit our medal-level sponsors!

Support provided by Ethicon, Inc.



ExH

iBiT

Or

S 20 ethicon, inc. Gold sponsor 15 Bk Medical SILVER SPONSOR 1 & 2 Medtronic Advanced Energy SILVER SPONSOR 23 Hitachi Aloka Medical, Ltd. BrONZE SPONSOr 5 & 6 intuitive Surgical BrONZE SPONSOr 13 Onyx Pharmaceuticals / Bayer HealthCare BrONZE SPONSOr 21 Edwards Lifesciences BrONZE SPONSOr 12 Sirtex Medical, Inc. BrONZE SPONSOr 14 Angiodynamics SPONSOR

9 Covidien SPONSOR 19 Pathfinder Technologies, Inc. SPONSOR

16 & 17 BTG

30 CanLiv Foundation

4 Carefusion

37 CAScination

22 ERBE USA

3 NeuWave Medical, Inc.

10 Novadaq Technologies, Inc.

26 RedPath Integrated Pathology

11 Sanofi

29 The Cholangiocarcinoma Foundation

24 Thompson Surgical Instruments, Inc.



ExHiBiTOr SHOwCASE

location: pompeii/promenade EXHIBIT HOURS

Thursday 5:15pm – 6:45pm

Friday 7:00am – 2:00pm and 5:00pm – 7:15pm

Saturday 7:00am – 11:15am EVENTS HELD IN EXHIBIT HALL

thursday

5:15pm – 6:45pm Welcome Reception

Friday

7:00am – 8:00am Continental Breakfast

10:00am – 10:30am Morning Beverage Break

1:00pm – 2:00pm Boxed Lunch & Video Presentations

6:30pm – 7:15pm Cocktail Reception & Highlighted Videos saturday

7:00am – 8:00am Continental Breakfast

10:45am – 11:15am Morning Break & Video Presentations EXHIBITOR PASSPORT Visit the exhibitors, complete your passport and enter a chance to win some wonderful raffle prizes, including an iPAD Air, complimentary 2015 meeting registration, a VIP Miami gift basket, and other exciting prizes. Visit our top sponsors and qualify for an extra raffle! Passport cards must be turned in to the AHPBA registration desk by Saturday afternoon.



AHPBA ExHiBiTOrS & SPONSOrS

angiodynamics SPONSOr BOOTH #14 14 Plaza Drive Latham, NY 12110 www.angiodynamics.com

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products.

bK Medical SILVER SPONSOR BOOTH #15 8 Centennial Drive Peabody, MA 01960 www.bkmed.com

The BK Medical Flex Focus 800 premium ultrasound system from Analogic is designed for the surgical suite. Supporting a comprehensive range of sterilizable transducers, it is compact, lightweight, and can be battery powered.

btG BOOTH #16 & 17 Five Tower Bridge, Suite 800 300 Barr Harbor Drive West Conshohocken, PA 19428 www.btgplc.com

BTG plc is an international specialist healthcare company developing and commercializing products targeting acute care, oncology and vascular diseases. We sell our products direct to customers in the US and elsewhere principally through distribution partners. We are focused in three business areas: Interventional Medicine, Specialty Pharmaceuticals and Licensing. Interventional Medicine comprises Interventional Oncology and Interventional Vascular products including drug-device combinations. Our Interventional Oncology products include embolization, chemoembolization and radioembolization beads which are used to treat patients with liver tumors.



AHPBA ExHiBiTOrS & SPONSOrS continued

Canliv Foundation BOOTH #30 164 Market Street, Suite 129 Charleston, SC 29401 www.canliv.org

CanLiv’s vision is to be the catalyst that brings together patients and their families affected by cancers of the bile duct, gall bladder, and liver with doctors, researchers and partners; and to create a community of stakeholders that will work together to advance research, improve patient outcomes, and search for the cure

Carefusion BOOTH #4 1500 Waukegan Rd. McGaw Park, IL 60085 www.carefusion.com

CareFusion delivers clinically proven products and services that measurably improve the productivity and safety of healthcare globally. The Pleurx® catheter system is the easy-to-use and effective choice for the home Management of recurrent pleural effusions and malignant ascites. With the PlerX In-dwelling catheter and vacuum bottles, patients can manage fluid accumulation through intermittent drainages at home, with minimal physician intervention.

Cascination BOOTH #37 3014 Bern, Switzerland www.cascination.com

CAScination AG manufactures and markets surgical navigation systems for soft tissue surgery, which enable precision guidance of surgical instruments during surgical interventions on the liver.

Covidien BOOTH #9 15 Hampshire Street Mansfield, MA 02048 www.covidien.com

Covidien is a $10 billion global healthcare products leader dedicated to innovation and long-term growth. Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Please visit http://surgical.covidien.com/




edwards lifesciences - SPONSOR BOOTH #21 1 Edwards Way Irvine, Ca 92614 www.edwards.com

Post-Surgical Recovery Resource Center: An initiative of Edwards Lifesciences…This Resource Center is designed to help you reduce the risk of post-surgical complications (including anastomotic leaks, AKI, SSI, UTI) in moderate to high-risk surgeries. Explore the data that support the standardization of Hemodynamic Optimization through Perioperative Goal-Directed Therapy; and see how this can work in conjunction with your ERAS or NSQIP initiative. Visit Edwards.com/PGDT to access resources immediately.

erbe usa BOOTH #22 2225 NW Parkway Marietta, GA 30067 www.erbe-med.com

ERBE USA presents the ERBEJET® 2, a unique modality for selective tissue dissection with precise, gentle pressure rather than intense heat. Using an extremely thin laminar water jet, it forces softer, more water-soluble tissue to separate, while fibrin-rich structures are spared. This optimizes the preservation of vessels, and ducts.

ethicon, inc. Gold sponsor bootH #20 4545 Creek Road Cincinnati, Ohio 45242 www.ethicon.com

The ETHICON brand is used for the products of Ethicon, Inc. and Ethicon Endo-Surgery, Inc., two companies with long histories of medical innovation, which provide globally a broad range of surgical technologies and products (including energy devices, sutures, staplers, clip appliers, trocars and meshes) used to treat colorectal and thoracic conditions, women’s health conditions, hernias, cancer and obesity. Ethicon, Inc. and Ethicon Endo-Surgery, Inc. are part of the Johnson & Johnson Family of Companies.

Hitachi aloka Medical, ltd. BRONzE SPONSOR BOOTH #23 10 Fairfield Boulevard Wallingford, CT 06942 www.hitachi-aloka.com

Hitachi Aloka Medical’s commitment to ultrasound for surgeons offers a wide range of consoles and specifically designed transducers to meet the needs of every surgeon. Recognized for our superior image quality, system reliability and use of cutting edge technology, we remain the standard in the field of ultrasound for surgeons.




intuitive surgical BRONzE SPONSOR BOOTH #5 & 6 1266 Kifer Road Sunnyvale, CA 94086 www.intuitivesurgical.com

Intuitive Surgical is the global leader in robotic-assisted, minimally invasive surgery. Its da Vinci® System enables general surgeons to offer complex procedures minimally invasively. da Vinci is used for bariatric, esophageal, colorectal and gallbladder surgery. da Vinci Single-Site is FDA cleared for cholecystectomy, providing gallbladder patients with virtually scarless results.

Medtronic advanced energySILVER SPONSOR BOOTH #1 & 2 180 International Drive Portsmouth, NH 03801 www.medtronic.com

Medtronic Advanced Energy products deliver proprietary Transcollation® technology, a combination of radiofrequency (RF) energy and saline that provides hemostatic sealing of soft tissue during surgery. The advanced energy product line has evolved from monopolar electrosurgical devices used in liver and pancreatic resection to the Aquamantys® System, which includes a bipolar electrosurgical generator and handheld disposable devices.

Medtronic’s monopolar and bipolar sealers have been used to treat patients across a wide range of surgical procedures, including surgical oncology, orthopaedic reconstruction, and spine surgery.

neuWave Medical, inc. BOOTH #3 3529 Anderson Street Madison WI 53704 www.neuwavemedical.com

NeuWave Medical offers an enhance portfolio, the CertusPR Ablation Probe is designed to produce ablations with limiting overall length. Each component of the device was designed with a specific clinical need in mind. The Certus 140 System maximizes synchronized power deliver to soft tissue, minimizes invasiveness, and provides a simple and ergonomically optimized user interface. Advanced features include Tissue Specific Probes, Tissu-LocTM Technology and Clic n’ GoTM connections. Don’t imagine the future see it now.




newlink Genetics Corporation SPONSOR 2503 South Loop Drive Suite 5100 Ames, IA 50010 www.linkp.com

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve treatment options for cancer patients. NewLink’s portfolio includes biologic and small-molecule immunotherapy product candidates intended to treat a wide range of oncology indications. NewLink’s product candidates are designed to harness multiple components of the immune system to combat cancer without significant incremental toxicity, either as a monotherapy or in combination with other treatment regimens. NewLink’s lead product candidate, algenpantucel-L (HyperAcute® Pancreas) is being

studied in a Phase 3 clinical trial in surgically resected pancreatic cancer patients (under a Special Protocol Assessment with the U.S. FDA) as well as in a separate study in locally advanced pancreatic cancer patients. NewLink has recently launched an adaptive design Phase 2B/3 clinical trial of tergenpumatucel-L (HyperAcute® Lung) in patients with non-small cell lung cancer. NewLink is developing indoximod, a small-molecule, orally bioavailable product candidate from NewLink›s proprietary indoleamine-(2,-3)-dioxygenase pathway inhibitor technology. NewLink is studying indoximod in various chemotherapy and immunotherapy combination studies independently and in collaboration with the National Cancer Institute. For more information please visit http://www.linkp.com. Patient information is available at http://www.pancreaticcancer-clinicaltrials.com.




novadaq technologies, inc. BOOTH #10 11091 Corsia Trieste Way, Unit 201 Bonita Springs, FL 34135 www.novadaq.com

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to radiation. More than 75 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs.

The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.

onyx pharmaceuticals / bayer HealthCare BOOTH #13 249 E. Grand Avenue South San Francisco, CA 94080 www.onyx.com

Bayer HealthCare and Onyx Pharmaceuticals are committed to cancer research and treatment options. We continually apply our experience, knowledge and passion to develop new cancer therapies.

pathfinder technologies, inc. SPONSOR BOOTH #19 2969 Armory Drive, Suite 100A Nashville, TN 37204 www.pathnav.com

Pathfinder Technologies offers state-of-the-art computer-assisted navigation and 3D surgical planning tools, enabling the optimal course of therapy for soft-tissue abdominal procedures.




redpath integrated pathology BOOTH #26 2515 Liberty Ave Pittsburgh, PA 15222 www.redpathip.com

RedPath Integrated Pathology is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. Our patented PathFinderTG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemmas in patients who are at risk of cancer. RedPath performs all clinical testing and R&D in its state-of-the-art, CLIA-certified and CAP-accredited laboratory.

RedPath’s platform is supported by more than 20 years of scientific and clinical research, and studies using it have been published in more than 200 peer-reviewed journals including The New England Journal of Medicine. Two recent healthcare economic studies demonstrate that the use of PathFinderTG significantly reduces healthcare costs. Based on the strong clinical data supporting our platform, RedPath has received positive coverage decisions from Medicare and several private payers. RedPath is committed to offering cutting-edge molecular diagnostic services to support gastroenterologists, pathologists, and other physicians by improving clinical management of patients.

sanofi BOOTH #11 www.sanofi.us

Sanofi Biosurgery is a global strategic business unit of Sanofi. It develops and markets innovative, biologically based products for osteoarthritis relief, adhesion prevention, temporary endovascular occlusion of blood vessels, cartilage repair, and severe burn treatment. Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).




sirtex Medical, inc. BOOTH #12 300 Unicorn Park Drive Woburn, MA 08101 www.sirtex.com

Sirtex, headquartered in Australia and with U.S. operations in Woburn, Mass., is a global life-sciences company that develops and delivers effective oncology treatments using novel small particle technology. Sirtex is committed to developing new procedures for the treatment of cancer while expanding the availability of Selective Internal Radiation Therapy (SIRT), also known as radiobmbolization to those in need.

Sirtex manufactures SIR-Spheres® microspheres, biocompatible resin microspheres (average 32uM diameter) that contain the beta emitting Yttrium 90 to kill cancer cells. SIRT is a proven technology for inoperable liver cancer that delivers doses of radiation directly to the site of tumors. In a minimally invasive treatment, millions of radioactive SIR-Spheres microspheres are infused via a catheter into the liver where they selectively target liver tumors with a dose of internal radiation up to 40 times higher than conventional radiotherapy, while sparing healthy tissue.

For more information and to explore our new Treatment Center Locator, visit www.sirtex.com.

the Cholangiocarcinoma Foundation BOOTH #29 5526 West 13400 South, #510 Salt Lake City, Utah 84096 www.cholangiocarcinoma.org

Founded in 2006, the Cholangiocarcinoma Foundation provides help for patients and caregivers, advocates for those afflicted and educates those who do not understand. The non-profit 501(c)(3) foundation is run solely by volunteers having lost a loved one to cholangiocarcinoma or suffering from cholangiocarcinoma and surviving. Our mission is to find a cure and improve the quality of life for those affected by bile duct cancer. As our reach continues to expand, we examine ways to improve diagnosis and early detection and advance therapies for prolonging life.

thompson surgical instruments, inc. BOOTH #24 10170 E. Cherry Bend Road Traverse City, MI 49684 www.thompsonsurgical.com Thompson Surgical Instruments, Inc. is the market leader in surgical retraction and the manufacturer of the original table mounted retractor.



SPECiAL THANKS TO Our

BrONZE SPONSOr



Just a few highlights of the many benefits of Fellowship in the Americas Hepato-Pancreato-Biliary Association!

The americas Heptao-pancreato-biliary association (AHPBA),an incorporated, nonprofit organization, was created with a vision of devoting itself to relieving the human suffering caused by HPB disorders throughout the world, by improving education, training, innovation, research and patient care. The AHPBA serves as the American Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA). Today, more than 1,000 multidisciplinary active members create the energy of our society. Together with surgeons, residents and fellows, allied health, interventional/diagnostic radiologists, gastroenterologists, medical and radiation oncologists, pathologists, transplantation physicians and scientists we meet, have fun and learn and collaborate. The AHPBA fosters an atmosphere of alliance among clinicians and scientists to advance both learning and patient care.

BENEFiTS OF MEMBErSHiPMembership in the AHPBA will provide you with an opportunity to belong to one of the most recognized organizations in the HPB field. Active member benefits include:

• Discounted registration rates at the annual meeting.

• E-access to subscriptions to the premier journal of our specialty, HPB.

• State-of-the-art consensus conferences and chapter meetings that keep you on the cutting edge of clinical care and research.

• Eligibility to apply for research grants, travel fellowships and awards.

• Opportunities to develop professional and social relationships with leaders in the field of gastrointestinal and HPB surgery.

AHPBA Membership Benefits



/AHPBA

/AHPBA

For more information on application

guidelines or to apply, please visit

www.ahpba.org/join

MEMBErSHiP dETAiLSactive Membership Open to any qualified medical practitioner or scientist actively involved in any of the hepatic, pancreatic or biliary fields. Annual dues for Active Membership are $250.

Candidate Membership Open to Residents of Fellows enrolled in a program of medical education or research. Candidate members must convert to active members at the conclusion of the training. Annual dues for Candidate Membership are $50.

allied Health Membership Open to health care providers who are not physicians or scientists. This includes, but is not limited to registered nurses, licensed practical nurses, clinical nurse practitioners, clinical trial managers, physician assistants, and technologists. Annual dues for Allied Health are $100. discounted Combined Memberships with the iHpba The AHPBA serves as the American Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA). Combined members enjoy full membership status in both the AHPBA and the IHPBA as well as discounted membership dues. Annual dues for Combined Active Membership are $217.50. Annual dues for Combined Candidate Membership are $32.50.

The AHPBA is a great place for HPB enthusiasts to meet, learn and collaborate!



americas Hepato-pancreato- biliary association 5019 W. 147th Street Leawood, KS 66224

Telephone: 913-402-7102 Fax: 913-273-9940 Email: [email protected] Web: www.ahpba.org /AHPBA/AHPBA

Join today!The AHPBA is a great place for HPB enthusiasts

to meet, learn and collaborate!



2013–2014 NEw MEMBErSAs of January 15, 2014

ACTIVE Daniel E. Abbott, MD - USA Hector Rodolfo Agnesio, MD - Argentina Jorge Mario Aguirre, MD - USA Angel E Alsina, MD - USA Juan Marcelo Alvarez, MD - Argentina Nayef Alzahrani, MD - Australia Gustavo Andreoli, MD - Uruguay Victoria Ardiles, MD - Argentina Gerardo F. Arroyo, MD - Argentina Elaine C. Ataide, PhD - Brazil Glaucio Baechat Costa, MD - Brazil Christian H. Bertona, MD - Argentina Gustavo Raul Bianco, MD - Argentina Ilka FSF Boin, MD - Brazil Eduardo Miraranda Brandao, MD - Brazil Fernando Bray Beraldo, MD - Brazil Jorge Bufaliza, MD - Argentina Edy Waldemar Caal Melendez, MD - Guatemala Felix Camasco, MD - Peru Eduardo Jose Cassone, MD - Argentina Igor Cermetia Farias, MD - Brazil Manuel Ceron Rodriguez, MD - Mexico Jose Chaman, MD - Peru Oscar Chapa, MD - Mexico Leonardo Simao Coelho Guimarael, MD - Brazil Moises Cukier, MD - Panama Antonio Moris Curry Filho, MD - Brazil Diego Cutropia, MD - Argentina Cassio Virgilio C. De Oliveira, MD - Brazil Vanderson de Oliveira Lemos, MD - Brazil Martin de Santibanes, MD - Argentina Raymison Monteiro de Souza, MD - Brazil

Hong Defei, MD - China Rafik A. Elsabrout, MD - USA Alejandro Ettlin, MD - Uruguay Ji Fan, MD - USA Marcelo Augusto Faria de Freitas, MD - Brazil Mary E Fischer, MD - USA Eduardo Alesandro Flores Villaba, MD - Mexico Fernando César Façanha Fonseca, MD - Brazil Charly Franklin Oporto Cossio, MD - Argentina Rogerio Aoki Fuziy, MD - Brazil Gabriel Eduardo Gondolesi, MD - Argentina Jose Enrique Gonzalez Herrera, MD - Mexico Cesar Gutierrez-Samperio, MD - Mexico Angel Luis Guzman Bonilla, MD - Dominican Republic Martin Harguindeguy, MD - Uruguay Hoover Rodyl Henriquez Cooper, MD - Honduras Marco Antonio Hernandez-Guedea, MD - Mexico Luis Montiel Hinojosa, MD - Mexico Jimmy Ronald Ixcayau Hernandez, MD - Guatemala Roberto Jauregui Brechu, MD - Mexico Prashant Khullar, MD - USA Gustavo Kohan, MD - Argentina Muthusamy Kunnimalaiyaan, MD - USA Daltro Lemos da Rosa, MD - Brazil Martin Abelleira Linardi, MD - Uruguay Roberto Carlos Lopez-Solis, MD - USA

Congratulations and Welcome to our Newest Members



2013–2014 NEw MEMBErS continued

As of January 15, 2014

ACTIVE continued Tamer A. Malik, MD - USA Rodrigo Maroni Veiga, MD - Argentina Baltazar Martinez-Navarrete, MD - Mexico Erin C. Maynard, MD - USA Martin McCarter, MD - USA Lucas Souto Nacif, MD - Brazil Carolina Nahime, MD - Brazil Eric Kaoru Nakakura, MD - USA Juan Jose Nunez, MD - Peru Ricardo Luis Oddi, MD - Argentina Lilin Oserio-Molina, MD - Mexico Houssam Osman, MD - USA Antonio Sanchez Pablo Jose, MD - Argentina Alejandro Eduardo Padilla Rosciano, MD - Mexico Haroldo Estuardo Paiz, MD - Guatemala Gustavo Andres Pazos, MD - Argentina Joaquin Pereyra, MD - Uruguay Rodrigo N. Pinheiro, MD - Brazil Juan Manuel Ponce-Ayala, MD - Mexico David Estuardo Porras, MD - Guatemala Vichin Chander Puri, MD - USA Carla Cecliia Ramirez Cabrera, MD - Guatemala Carlos Vicente Ramirez Castillo, MD - Mexico Lizka Lorena Richards, MD - USA Mauricio Rodriguez Bravo, MD - Panama Carlos Rodriguez Montalvo, MD - Mexico

Federico Roesch Dietlen, MD - Mexico Luis Ruso Martinez, MD - Uruguay Carlos Federico Salas, MD - Argentina Leonardo Nelson Santamaría, MD - Panama Luis Ernesto Sarotto, MD - Argentina Luke O. Schoeniger, MD, PhD - USA Victor Audon Serrano, MD - Argentina Jorge Luis Silva, MD - Argentina Erick Roberto Soto Solís, MSc, MACG - Guatemala Roberto Ricardo Taruselli, MD - Uruguay Swee Teh, MD - USA Rogelio A Traverso, MD - Argentina Steven D. Trocha, MD - USA Fabiola Trocoli Novaes, MD - Brazil Mauro Enrique Tun Abraham, MD - Mexico Marcos Alfmejo Uffelmann, MD - Argentina Carlos Hector Valenzuela, MD - Argentina Roberto Valinas, MD - Uruguay Jorge Arturo Vazquez Reta, MD - Mexico Fernando Viava Hummel Filho, MD - Brazil Sandeep Suresh Vijan, MBBS - USA Mario Vilatoba, MD - Mexico Bruno Voz de Melo, MD - Brazil Andrew L. Warshaw, MD - USA Jared A. White, MD - USA Gary Xiao, MD - USA Peter S. Yoo, MD - USA Kito Young Gonzalez, MD - USA Daniel Zamora-Valdes, MD - Mexico



2013–2014 NEw MEMBErS continued

As of January 15, 2014

ALLIED HEALTH Marianne Andersen - Denmark Cesar Aviles - USA Beverley A. Burnett, RN - Canada Jenell L. Gilman, PA-C - USA Mary Beth Henry, NP - USA Tawana N. Overton - USA Sarah A. Reed, PA-C - USA Lori Saathoff, RN - USA Jose Hector Salazar, MD - Mexico Leigh Samp - USA Amit Sastry - USA Meranda Scherer, BSN, RNFA - USA Stacey M. Schulte, AGPCNP-BC - USA Gary Duran Zuniga, MD - Argentina CANDIDATE Steven C. Agle, MD - USA Farzad Alemi, MD - USA Noaman Syed Ali, MD - USA Kimon Orson, Isles, Dasent Bonadie, MB, BS, DM - Canada Melanie-Antonietta Brown, MD - USA Jesse Clanton, MD - USA Kelly M. Collins, MD - USA Matthew R. Dimon, MD - USA Alvaro Andres Andres Duarte Garces, MD - Colombia Mohamed Hosny Elgamal, MD - USA Andrew I. Gagnon, MD - USA Monique A. Gary, MD - USA Mai-Kim Gervais, MD - Canada Chad R. Gonczy, MD - USA Jan Grendar, MD - Canada Julie Hallet, MD - Canada Hishaam Ismael, MD - USA

Furrukh Jabbar, MD - USA Maris S. Jones, MD - USA Sunhawit Junrungsee, MD - USA Ashwin Kamath, MD - USA Ahmed Kandeel, MD - USA Goutham Kumar, MD - USA Victor Kuo, MD - USA Jerome M. Laurence, MBChB, PhD - Canada Julie N. Leal, MD - USA Ahmad Abdullah Madkhali, MD - Canada Maher M. Matar, MD - Canada Paulo Roberto Mesquita, MD - Brazil Christoph W. Michalski, MD - USA Indraneil Mukherjee, MD - USA Julia Ng, MD - USA Daniel P. Nussbaum, MD - USA Puraj Patel, DO - USA Pejman Radkani, MD - USA Juan Carlos C. Sabogal Olarte, MD - Canada Teviah Sachs, MD, MPH - USA Aaron C. Saunders, MD - USA Kevin Naresh Shah, MD - USA Murtaza Shakir, MD - USA Christopher R Shubert, MD - USA Karen P. Solis, MD - Mexico Malcolm Hart Squires, MD – USA Aimee L. Strong, NP - USA Iswanto Sucandy, MD - USA Anselm Jingwa Tintinu, MD - USA Vicente Valero III, MD - USA George Younan, MD - USA Kai Zhang, MD - USA



www.myhpb.com

This platform has been developed to facilitate access to the highest quality resources and to enable interaction with like minded individuals.

Join IHPBA and benefit from this new innovative platform

www.ihpba.org

myHPB is an innovative new elearning platform providing IHPBA members with up-to-date, quality-assured content, including

masterclass videos and key educational resources as well as a meeting space to discuss the latest developments in our specialty field.

Search myHPB

myHPB provides IHPBA members with up-to-date, quality-assured content including, masterclass videos and key educational resources, as well as a meeting space to discuss the latest developments in the field.

How myHPB works

FIND OUT MORE FIND OUT MORE FIND OUT MORE

1. Browse &Search Content

2. Complete CPD& Create Content

3. Complete yourProfile

View our full library of content. Search forcontent that matters to you by keyword orbrowse full CPD modules by topic.

Contribute to the discussion and completemodules. Earn your CPD points.

Complete your online profile for moremeaningful interactions with other myHPBusers and show your activity.

Inbox Profile Logout

Welcome, David

myHPB | About myHPB | Browse Content | Video Masterclass | Discussions | Guidelines | Case of the Month | Fellowships

IHPBA Advert for AHPBA.indd 1 03/02/2014 12:36AHPBA_2014_FinalProgram-CMYKconvert.indd 134 2/12/14 9:40 AM


iHPBA / KENNETH wArrEN FOuNdATiON dONOrS

The Kenneth Warren Foundation promotes collaborative scientific discovery in hepatic, biliary, or pancreatic diseases through support of clinical or laboratory research for a young investigator in a laboratory outside the applicant’s own department and country. Fellowships, funded by the Foundation, support the recipient’s own salary; further details on the history and goals of the Foundation are detailed on the IHPBA website, http://www.ihpba.org/42_IHPBA-Warren-Fellowship.html.

We are proud to recognize our donors and would like to thank all of the organizations and individual supporters whose continued generosity allows us to continue this important work.

WARREN FAMILy CIRCLE $100,000 and up

Kenneth Warren

Thomas Warren

INTERNATIONAL LIFE CIRCLE $50,000 to $99,999

Wiley Blackwell

RESEARCH STEWARDS CIRCLE $25,000 to $49,999

Americas Hepato-Pancreato-Biliary Association (AHPBA)

International Hepato-Pancreato- Biliary Association (IHPBA)

SUSTAINERS $10,000 to $24,999

Australia and New Zealand Hepatic, Pancreatic and Biliary Association (ANZHPBA)

European-African Hepato-Pancreato- Biliary Association (E-AHPBA)

O. James Garden

C. Wright Pinson

Henry A. Pitt

Sally Warren



iHPBA / KENNETH wArrEN FOuNdATiON dONOrS continued

LEADERS $1,000 to $9,999

Asian-Pacific Hepato-Pancreato- Biliary Association (A-PHPBA)

Markus Büchler

John L. Cameron

Carlos Fernandez-del Castillo

Dirk Joan Gouma

W. Scott Helton

Joan E. Kolligan

Joseph W.Y. Lau

Yuji Nimura

James Toouli

George Warren

BENEFACTORS $500 to $999

Michael D’Angelica

Jacques Belghiti

William R. Jarnagin

Chen-guo Ker

Sean Mulvihill

Glenn D Steele

Thomas van Gulik

SPONSORS $250 to $499

Christoph Ausch

Mark Callery

John W. Chen

Roland Montenegro Costa

Carlos Florez-Zorilla

Ellen Hagopian

Clem Imrie

Palepu Jagannath

Yoshifumi Kawarada

Basil P. Kekis

Satoshi Kondo

Mickael Lesurtel

Michelle Molinari

Maris Pavars

Alvarao Riart

Karl Sondenaa

Steven Strasberg

Cheng-hsi Su

Miguel Angel Suarez Munoz

Atushi Sugioka



iHPBA / KENNETH wArrEN FOuNdATiON dONOrS continued

FRIENDS $100 to $249

Eduardo Akaishi

Mohammed Alsaghier

Taku Aoki

Gerard Aranha

Takehide Asano

Telesforo Bacchella

Giulio Belli

Neil Anthony Berry

Andrew Biankin

Giulio Belli

Christoph Broelsch

Matteo Cescon

Julian Choi

Eduardo de Santibanes

Horacio D’Agostino

Georgios Glantzounis

Mehmet Haberal

Ho-seong Han

Thomas Howard

Oscar Imventarza

Timoleon Kakavoulis

Santeev Kanoria

Wolfram Trudo Knoefel

Nobuaki Kurauchi

Roberto Lauro

Sung-gyu Lee

Michael Ka Wah Li

Fabio Madureira

Sameer Mihrshahi

Kohji Miyazaki

Gareth Morris-Stiff

Satvinder Mudan

Akimasa Nakao

Attila Nakeeb

Leslie Nathanson

Overgaard Nielson

Gregory Nolan

Stefano Puleo

Guntars Pupelis

Renyi Qin

Samuel Ramos Linaje

Norbert Senninger

Harjit Singh

Shin Takasaki

Jorge H. Tobar de Leon

Guido Torzilli

Evangelos C. Tsimoyiannis

Tjarda van Heek

Andrew Warshaw

Robin Williamson

To make a donation, please go to the IHPBA website http://www.ihpba.org/48_Charitable-Donations.html , or do so when renewing your IHPBA dues.



diSCLOSurES

ABSTRACT AUTHORS

The following Abstract Authors provided information to be disclosed. jean-Michel Aubin Covidien Canada Role: Research Bursary Steven Bokshan Pathfinder Role: Dr. William Chapman is President of Pathfinder, 3D image guidance company. Fernando Dip Karl Storz Received: Funding and equipment provided by Karl Storz yuri Genyk Takeda Role: Employee Major Lee ACS (not For Profit) BLH Is A Paid Consultant To The (not-for-profit) ACS As A Director Of NSQIP zhenyu Xiao Vasculox, Inc. St Louis Role: Co-founder, Stockholder And Employee Of Vasculox, Inc, A Biotech Start-up Company That Is Developing Protein Therapeutics For Several Indications.



diSCLOSurES continued

Mark bloomston Ohio State University Role: Presenter Consultant - Covidien William Chapman Washington University St. Louis Role: Presenter President Of Pathfinder Therapeutics, Inc - A company for 3D image guidance sean Cleary University of Toronto Role: Moderator Consultant - Roche sebastian de la Fuente Florida Hospital Orlando and Univ of Central Florida Role: Moderator Consultant - TransEnterix Speaker’s Bureau, Novadaq Technologies paul Hansen Providence Portland Cancer Center Role: Presenter, Moderator Consultant, Angiodynamics William Hutson University of Maryland Role: Presenter Received: Grant/Research Support Roche; Ocera

david iannitti Carolinas Medical Center Role: Presenter Consultant, Covidien Received: Grant/Research Support - Covidien John Martinie Department of General Surgery, Carolinas Medical Center Role: Proctor Intuitive Surgical a. James Moser Beth Israel Deaconess/Harvard Medical School Role: Presenter, Course Director Consultant - AbbVie sharona ross AHPBA Program Committee Member Received: Women in Surgery Grant from Covidien Other: Speaking Honorarium - Olympus shimul shah AHPBA Program Committee Member Role: Consultant - Covidien, Novartis, Bayer Self/Spouse Jean-nicolas vauthey MD Anderson Cancer Center Role: Presenter Speaker’s Bureau - Roche, Novartis Received: Grant/Research Support - Roche

SPEAkERS, MODERATORS, DISCUSSANTS

The following Speakers/Moderators/Discussants provided information to be disclosed.



iN MEMOriAM

Hector orozco, Md, 1935-2013

Hector Orozco MD, FACS a lifetime member and active supporter of the AHPBA passed on September 28th 2013 at his home in Sahuayo Michoacán, Mexico.

Dr. Orozco was born in 1935 in Sahuayo, a small town near Guadalarjara in Western México. He received his MD at The Universidad Autonoma de Guadalajara. He completed a residency in internal medicine followed by surgery at the most prestigious academic center in Mexico, Instituto Nacional de la Nutricion, Mexico City. His ambition to become the best possible surgeon posible led him to pursue additional training in the United States and so he completed a second surgical

residency at The Graduate Hospital in Philadelphia, Penn. He returned to The Instituto Nacional de la Nutricion, where he spent the next 40 years of his life and also became Profesor and Chairman of The Departent of Surgery (1988-2007). During his tenure developed a world reknowned portal hypertension clinic, performed more than 1,000 operations for portal hypertension, and was principle investigator on some of the most important clinical trials ever performed in portal hypertension. He began the liver transplant program in Mexico and performed the first heterotopic transplant in 1976 and the first orthotopic liver transplant in 1985. According to his life long colleague and friend Miguel Mercado, Hector “became widely recognized as the best and most influential academic surgeon in Mexico. He was an exceptional human being and surgeon who inspired and mentored several generations of academic Surgeons”.

One of Dr. Orozco’s life long ambitions was to train and prepare a future generation of Mexican Surgeons who could best meet the health care needs of Mexico. He recognized that to elevate clinical excellence would require better education and training than what was available in Mexico at the time he became chair of surgery. For this reason, he established a collaboration with The University of Alabama, Birmingham and a mandatory surgical rotation for his surgical residents, which continues to this day. In addition, he sent many of his young faculty to specialized centers around the World to acquire expertise in HPB disease and Surgery and then hired them to join his faculty. Through these efforts, Hector recognized the importance and value of academic international exchange across the Americas. So, when the AHPBA first convened in 1991, Dr. Orozco

Hector Orozco, MD



iN MEMOriAM continued

became one of its original members and remained one of its strongest advocates. He attended every single anual meeting and was always accompanied by his lovely wife, Silvia. He inspired his faculty, residents, and other Latin American Surgeons to attend the AHPBA anual meeting. To further develop and strengthen academic relationships between the AHPBA and Mexico, Dr. Orozco invited four or five members of the AHPBA from the United States each year to lecture at the annual Mexican GI Surgery Symposium held at his hospital in Mexico City. The social, cultural and intellectual exchange that occured at these meetings over the years clearly contributed to the growth and success of the AHPBA.

Dr. Orozco was a member of the most important academic societies in Mexico, President of the Mexican Association of Gastroenterology and the Mexican Association of Hepatology. He was also an honorary member at The American Surgical Association and American College of Surgeons.

Hector was an unselfish and caring human and his life time dream was to return to his native rural community of Sahuayo to practice medicine. So, when he resigned in 2007 as Chairman from The Instituto Nacional de Nutrición, he returned home and offered his surgical expertise to the people of Michoacán in the public hospital named after him. He felt strongly that since he had been given so much in his life that he would attend only to the poor and underserved and to not charge for his services. He also lectured and taught medical students at the University of Guadalajara without compensation. He continued this service for six years up until his untimely death.

Hector’s life as an academic surgeon symbolizes many of the founding principles of the AHPBA: scholarship, education, mentorship, outreach and social engagement. The AHPBA was fortunate to have him as an engaged and active member. I suspect that if he had a wish for the future for the AHPBA it would be to continue our efforts at international Academic Exchange and further our humanitarian outreach efforts throughout The Americas.

Hector Orozco was a friend to everyone he met, a reverred mentor, a passionate scholar, charismatic leader, a gifted surgeon and ambassodor for Mexican and Latin American Surgeons. He is survived by his wife Silvia and his three children: Adrian, Paulo and Julian. While Hector will be sadly missed he will be forever remembered by the convivient personality and infectious smile he brought with him every year to the AHPBA.

Submitted by Scott Helton, MD and Miguel Mercado, MD



March 11–15, 2015 Eden roc in Miami Beach, FL

SAVE THE DATE

Annual Meeting



AHPBA FuTurE MEETiNgS

2015

aHpba 2015 annual Meeting March 11-15, 2015 Eden Roc, Miami Beach, FL 2016

12th World Congress of the iHpba April 19-23, 2016 Sao Paulo, Brazil

Watch the website for updates www.ahpba.org

5019 W. 147th StreetLeawood, KS 66224

Telephone: 913-402-7102 Email: [email protected]: 913-273-9940 Web: www.ahpba.org



NOTES


final program - ahpbanov 14, 2017 · 7–9 leadership & administrative team 10–13 general...

Documents